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Abstract Catechol dehydroxylation is a central chemical transformation in the gut microbial
metabolism of plant- and host-derived small molecules. However, the molecular basis for this
transformation and its distribution among gut microorganisms are poorly understood. Here, we
characterize a molybdenum-dependent enzyme from the human gut bacterium Eggerthella lenta
that dehydroxylates catecholamine neurotransmitters. Our findings suggest that this activity
enables E. lenta to use dopamine as an electron acceptor. We also identify candidate
dehydroxylases that metabolize additional host- and plant-derived catechols. These dehydroxylases
belong to a distinct group of largely uncharacterized molybdenum-dependent enzymes that likely
mediate primary and secondary metabolism in multiple environments. Finally, we observe catechol
dehydroxylation in the gut microbiotas of diverse mammals, confirming the presence of this
chemistry in habitats beyond the human gut. These results suggest that the chemical strategies
that mediate metabolism and interactions in the human gut are relevant to a broad range of
species and habitats.
Introduction
The human gastrointestinal tract is one of the densest microbial habitats on Earth. Possessing 150-
fold more genes than the human genome, the trillions of organisms that make up this community
(the human gut microbiota) harbor metabolic capabilities that expand the range of chemistry taking
place in the body (Koppel et al., 2017; Qin et al., 2010; Sender et al., 2016). Microbial metabolism
affects host nutrition and health by breaking down otherwise inaccessible carbohydrates, biosynthe-
sizing essential vitamins, and transforming endogenous and exogenous small molecules into bioac-
tive metabolites (Koppel and Balskus, 2016). Gut microbial activities can also vary significantly
between individuals, affecting the toxicity and efficacy of drugs (Zimmermann et al., 2019;
Koppel et al., 2018; Gopalakrishnan et al., 2018; Wallace et al., 2010; Haiser et al., 2013), sus-
ceptibility to infection (Buffie et al., 2015; Devlin and Fischbach, 2015), and host metabolism
(Yao et al., 2018; Romano et al., 2017). To decipher the biological roles of gut microbial metabo-
lism, it is critical that we uncover the enzymes responsible for prominent transformations. This will
not only increase the information gained from microbiome sequencing data but may also illuminate
strategies for manipulating and studying microbial functions. Yet, the vast majority of gut microbial
metabolic reactions have not yet been linked to specific enzymes.
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A prominent but poorly understood gut microbial activity is the dehydroxylation of catechols
(1,2-dihydroxylated aromatic rings), a structural motif commonly found in a diverse range of com-
pounds that includes dietary phytochemicals, host neurotransmitters, clinically used drugs, and
microbial siderophores (Wilson et al., 2016; Ozdal et al., 2016; Yang et al., 2007) (Figure 1A). Dis-
covered over six decades ago, catechol dehydroxylation is a uniquely microbial reaction that selec-
tively replaces the para hydroxyl group of the catechol with a hydrogen atom (Scheline et al., 1960)
(Figure 1A). This reaction is particularly challenging due to the stability of the aromatic ring system.
Prominent substrates for microbial dehydroxylation include the drug fostamatinib (Sweeny et al.,
2010), the catecholamine neurotransmitters norepinephrine and dopamine (Smith et al., 1964;
Sandler et al., 1971), the phytochemicals ellagic acid (found in nuts and berries), caffeic acid (a uni-
versal lignin precursor in plants), and catechin (present in chocolate and tea) (Peppercorn and Gold-
man, 1972; Cerda´ et al., 2005; Takagaki and Nanjo, 2010) (Figure 1B). Dehydroxylation alters the
bioactivity of the catechol compound (Kim et al., 2016; Ryu et al., 2016) and produces metabolites
that act both locally in the gut and systemically to influence human health and disease
(Sweeny et al., 2010; Ryu et al., 2016; Kang et al., 2016; Pietinen et al., 2001; Mabrok et al.,
2012; Maini Rekdal et al., 2019; Singh et al., 2019). However, the gut microbial enzymes responsi-
ble for catechol dehydroxylation have remained largely unknown.
We recently reported the discovery of a catechol dehydroxylating enzyme from the prevalent
human gut Actinobacterium Eggerthella lenta. This enzyme participates in an interspecies gut micro-
bial pathway that degrades the Parkinson’s disease medication L-dopa by catalyzing the regioselec-
tive p-dehydroxylation of dopamine to m-tyramine (Maini Rekdal et al., 2019). To identify the
enzyme, we grew E. lenta strain A2 with and without dopamine and used RNA sequencing (RNA-
seq) to find genes induced by dopamine. Only 15 genes were significantly upregulated in the pres-
ence of dopamine, including a putative molybdenum-dependent enzyme that was induced >2500
eLife digest Inside the human gut there are trillions of bacteria. These microbes are critical for
breaking down and modifying molecules that the body consumes (such as nutrients and drugs) and
produces (such as hormones). Although metabolizing these molecules is known to impact health and
disease, little is known about the specific components, such as the genes and enzymes, involved in
these reactions.
A prominent microbial reaction in the gut metabolizes molecules by removing a hydroxyl group
from an aromatic ring and replacing it with a hydrogen atom. This chemical reaction influences the
fate of dietary compounds, clinically used drugs and chemicals which transmit signals between
nerves (neurotransmitters). But even though this reaction was discovered over 50 years ago, it
remained unknown which microbial enzymes are directly responsible for this metabolism.
In 2019, researchers discovered the human gut bacteria Eggerthella lenta produces an enzyme
named Dadh that can remove a hydroxyl group from the neurotransmitter dopamine. Now, Maini
Rekdal et al. – including many of the researchers involved in the 2019 study – have used a range of
different experiments to further characterize this enzyme and see if it can break down molecules
other than dopamine. This revealed that Dadh specifically degrades dopamine, and this process
promotes E. lenta growth.
Next, Maini Rekdal et al. uncovered a group of enzymes that had similar characteristics to Dadh
and could metabolize molecules other than dopamine, including molecules derived from plants and
nutrients in food. These Dadh-like enzymes were found not only in the guts of humans, but in other
organisms and environments, including the soil, ocean and plants.
Plant-derived molecules are associated with human health, and the discovery of the enzymes that
break down these products could provide new insights into the health effects of plant-based foods.
In addition, the finding that gut bacteria harbor a dopamine metabolizing enzyme has implications
for the interaction between the gut microbiome and the nervous system, which has been linked to
human health and disease. These newly discovered enzymes are also involved in metabolic reactions
outside the human body. Future work investigating the mechanisms and outputs of these reactions
could improve current strategies for degrading pollutants and producing medically useful molecules.
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Figure 1. An enzyme from the prevalent human gut Actinobacterium Eggerthella lenta specifically metabolizes catecholamines that are available in the
gut. (A) The catechol structural motif is dehydroxylated by the gut microbiota. (B) Examples of catechols known to be dehydroxylated by gut microbes.
Red indicates the carbon-oxygen bond that is broken or the hydroxyl group that is removed in the dehydroxylation reaction. (C) Activity of natively
purified Dadh towards a panel of physiologically relevant catechol substrates. Enzyme (0.1 mM) was incubated with substrate (500 mM) for 22 hr at room
Figure 1 continued on next page
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fold. Hypothesizing this gene encoded the dopamine dehydroxylase, we purified the enzyme from
E. lenta and confirmed its activity in vitro. Dopamine dehydroxylase (Dadh) is predicted to bind bis-
molybdopterin guanine nucleotide (bis-MGD), a complex metallocofactor that contains a catalytically
essential molybdenum atom (Hille et al., 2014). Our previous work illuminated a role for Dadh in
dopamine metabolism by pure strains and complex communities. Here, we sought to explore the
substrate scope of Dadh and its broader role in catechol dehydroxylation by the gut microbiota.
Results
A molybdenum-dependent enzyme from Eggerthella lenta specifically
metabolizes catecholamines that are available in the gut
Because the human gut microbiota metabolizes a range of catecholic compounds (Figure 1B), we
first investigated whether the recently discovered Dadh possessed promiscuous dehydroxylase activ-
ity. We evaluated the reactivity of natively purified E. lenta A2 Dadh towards a panel of established
or potential host- and diet-derived catechol substrates (Supplementary file 1a and Figure 1—figure
supplement 1). This enzyme displayed a narrow substrate scope, metabolizing only dopamine and
the structurally related neurotransmitter norepinephrine, which differ only by the presence of a ben-
zylic hydroxyl group (Figure 1C). To identify the elements necessary for substrate recognition by
Dadh, we profiled its activity towards synthetic and commercially available dopamine analogs
(Figure 1D, Figure 1—figure supplement 1, and Supplementary file 1b). We found that Dadh tol-
erated only minor modifications to the dopamine scaffold, including a single N-methylation and the
presence of additional hydroxyl groups on the aromatic ring (Figure 1E). The catechol moiety was
absolutely necessary for activity, and dehydroxylation required that at least one hydroxyl group be
in the para position relative to the aminoethyl substituent. These data demonstrated that Dadh spe-
cifically recognizes the catecholamine scaffold.
This result prompted us to explore whether the transcriptional regulation of Dadh displayed simi-
lar specificity. Thus, we cultured E. lenta A2 in the presence of a subset of the dopamine analogs
that we had tested in the previous experiment, measured dehydroxylation using liquid chromatogra-
phy-mass spectrometry (LC-MS), and profiled the global transcriptome using RNA-seq. We found
that the regulation of dadh was also specific for the catecholamine scaffold (Figure 1F,
Supplementary file 1c). While the catecholamines dopamine and norepinephrine induced dadh
expression and were dehydroxylated by E. lenta, analogs lacking the catechol (analog 1 in
Figure 1D) or having a shorter side chain (analog 9 in Figure 1D) did not induce a transcriptional or
metabolic response (Figure 1F, Supplementary file 1c) (Maini Rekdal et al., 2019). Together with
our biochemical results, these transcriptional data suggest that Dadh may have evolved for the pur-
pose of catecholamine neurotransmitter metabolism in E. lenta. We propose that dopamine is an
endogenous substrate of this enzyme, because it was the best substrate both in vitro and in vivo,
Figure 1 continued
temperature, followed by analysis using LC-MS. Bars represent the mean ±the standard error (SEM) of three biological replicates (enzyme reactions).
This experiment was repeated three times. See Supplementary file 1a for the full chemical structures. (D) Dopamine analogs evaluated in this study.
(E) Activity of natively purified Dadh towards dopamine analogs in C). Enzyme (0.1 mM) was incubated with substrate (500 mM) for 22 hr at room
temperature, followed by analysis using LC-MS. Bars represent the mean ±the SEM of three biological replicates (enzyme reactions). See
Supplementary file 1b for the full chemical structures. This experiment was performed three times. (F) Transcriptional induction and whole-cell
dehydroxylation activity of E. lenta A2 in response to dopamine and a subset of dopamine analogs (500 mM each). Transcriptional induction was
assessed using RNA-seq, with the fold induction shown on the x-axis (foldchange >2, FDR < 0.01). To assess whole-cell metabolism, E. lenta was grown
anaerobically for 48 hr in BHI medium with 500 mM of each substrate, and the culture supernatant was analyzed for dehydroxylated metabolites using
LC-MS. RNA-sequencing data represent the log2fold change from n = 3 independent cultures for each condition (compound/vehicle). The metabolism
data represent the mean ±the SEM of three biological replicates (independent bacterial cultures). The culturing and analysis of metabolism was
performed twice, while RNA-sequencing was done once. All raw data from Figure 1 can be found in Figure 1—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Data from Dadh enzyme reactions and from studies of dadh regulation (Figure 1).
Figure supplement 1. SDS-PAGE of natively purified dopamine dehydroxylase from E. lenta A2.
Figure supplement 2. Proposed mechanism for dopamine dehydroxylation by E. lenta A2 dopamine dehydroxylase.
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induced the highest levels of expression in E. lenta, and is produced at substantial levels within the
human gastrointestinal tract (Eisenhofer et al., 1997).
In addition to uncovering a preference for the catecholamine scaffold, the substrate scope of
Dadh reveals potential mechanistic distinctions between this enzyme and the only other biochemi-
cally characterized reductive aromatic dehydroxylase, 4-hydroxybenzoyl Coenzyme A (CoA) reduc-
tase (4-HCBR) (Unciuleac et al., 2004). 4-HCBR is a distinct molybdenum dependent-enzyme
containing a monomeric molybdopterin co-factor that uses a Birch reduction-like mechanism to
remove a single aromatic hydroxyl group from 4-hydroxybenzoyl CoA. While 4-HCBR requires an
electron-withdrawing thioester group to stabilize radical anion intermediates (Unciuleac et al.,
2004), Dadh does not require an electron-withdrawing substituent and can tolerate additional elec-
tron-donating hydroxyl groups (Figure 1D and E, analogs 11–13). We preliminarily propose a mech-
anism for Dadh in which the dopamine p-hydroxyl group coordinates to the molybdenum center.
This could be followed by tautomerization of the m-hydroxyl group to a ketone with protonation of
the adjacent carbon atom. Oxygen atom transfer to molybdenum could be accompanied by rearo-
matization, providing the dehydroxylated product (Figure 1—figure supplement 2). Our proposal is
consistent with the postulated mechanisms of other oxygen transfer reactions catalyzed by bis-MGD
enzymes (Tenbrink et al., 2011; Hille et al., 2014).
Dopamine promotes gut bacterial growth by serving as an alternative
electron acceptor
The specificity of Dadh for dopamine suggested this metabolic activity might have an important
physiological role in E. lenta. We noted the chemical parallels between catechol dehydroxylation
and reductive dehalogenation, a metabolic process in which halogenated aromatics serve as alterna-
tive electron acceptors in certain environmental bacteria (Holliger et al., 1998). This insight inspired
the hypothesis that dopamine dehydroxylation could serve a similar role in gut bacteria. While we
observed no growth benefit when E. lenta was grown in complex BHI medium containing dopamine
(Figure 2—figure supplement 1), we found that including dopamine in a minimal medium lacking
electron acceptors (basal medium) increased the endpoint optical density of E. lenta cultures
(Figure 2A). This growth-promoting effect was only observed in dopamine-metabolizing E. lenta
strains, as non-metabolizing strains that express an apparently inactive enzyme (Maini Rekdal et al.,
2019) did not gain a growth advantage (Figure 2A and Figure 2—figure supplement 2). The effect
of dopamine on E. lenta contrasts with recent studies of digoxin, a drug that is reduced by E. lenta
without impacting growth in the same medium (Koppel et al., 2018).
We further investigated the relationship between dopamine and bacterial growth in the metabo-
lizing strain E. lenta A2. The growth increase observed in response to dopamine was dose-depen-
dent (Figure 2—figure supplement 3), mirrored the effects of the known electron acceptors DMSO
and nitrate (Koppel et al., 2018; Sperry and Wilkins, 1976), and did not derive from the product of
dopamine dehydroxylation, m-tyramine (Figure 2B). Additionally, the growth benefit was directly
tied to dopamine dehydroxylation. Inclusion of tungstate in the growth medium, which inactivates
the big-MGD cofactor of Dadh, blocked metabolism and inhibited the growth increase. In contrast,
inclusion of molybdate in the growth medium did not impact growth or metabolism (Figure 2B and
Figure 2—figure supplement 4). Molybdate and tungstate alone did not impact E. lenta A2 growth
in the basal medium (Figure 2—figure supplement 5). Taken together, these results indicate that
active metabolism of dopamine provides a growth advantage to E. lenta, likely by serving as an
alternative electron acceptor.
We next examined whether dopamine could promote E. lenta growth in microbial communities.
First, we competed dopamine metabolizing and non-metabolizing E. lenta strains in minimal
medium. E. lenta is genetically intractable, preventing the use of engineered plasmids encoding
defined fluorescence or antibiotic resistance as markers of strain identity. Instead, we took advan-
tage of intrinsic differences in tetracyline (Tet) resistance to differentiate the closely related strains in
pairwise competitions (Bisanz et al., 2018). Inclusion of dopamine in growth medium significantly
increased the proportion of the metabolizer relatively to the non-metabolizer in this competition
experiment (p<0.001, two-tailed unpaired t-test) (Figure 2C and Figure 2—figure supplement 6).
This was driven by the growth increase of the metabolizer rather than a decrease in the non-metabo-
lizer (Figure 2C and Figure 2—figure supplement 6).
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Figure 2. Dopamine increases gut bacterial growth by serving as an alternative electron acceptor. (A) Growth of dopamine metabolizing and non-
metabolizing E. lenta strains in minimal medium limited in electron acceptors (basal medium) containing 10 mM acetate. Strains were grown
anaerobically for 48–72 hr at 37˚C before growth was assessed. Bars represent the mean ±the SEM of three biological replicates (bacterial cultures). The
experiment was performed once. (B) Tungstate inhibits of growth and dopamine metabolism by E. lenta A2 in basal medium containing 10 mM
Figure 2 continued on next page
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Next, we explored the impact of dopamine on Tet-resistant E. lenta in the presence of a defined
bacterial community representing the major phylogenetic diversity in the human gut (Figure 2D and
Supplementary file 1d) (Devlin et al., 2016; Romano et al., 2015). We found that including dopa-
mine in the medium boosted the growth of metabolizers by an order of magnitude while non-
metabolizing strains did not gain a growth advantage (Figure 2D). Finally, we evaluated the impact
of dopamine on E. lenta strains present in complex human gut microbiotas. We cultured fecal sam-
ples from 24 unrelated subjects ex vivo in the presence and absence of dopamine and used qPCR to
assess the abundance of E. lenta and dadh. We found that both dadh and E. lenta significantly
increased by an order of magnitude in cultures containing dopamine (p<0.005, two-tailed unpaired
t-test) (Figure 2E) (Figure 2—figure supplement 7). Finally, we amplified the full length dadh gene
from these cultures and sequenced the region harboring the SNP that distinguishes metabolizing
and non-metabolizing strains (Maini Rekdal et al., 2019). These assays indicated that the increase in
dadh abundance in the complex communities was accompanied by a shift from a mixture of inactive
and active dadh variants to a dominance of the metabolizing R506 variant (p<0.01, Fisher’s exact
test) (Figure 2F). Finally, we noticed in these growth assays that a small number of samples did not
display an increase in E. lenta or dadh abundance (n = 4 and n = 3 samples, respectively) (Figure 2E
and Figure 2—figure supplement 7). While the factors influencing this outcome are unclear, they
could include the possibility that these specific communities support the growth of E. lenta in other
ways that such that dopamine metabolism does not provide any additional advantage, that these
samples contain inhibitory factors, or that organisms not targeted by our primers were responsible
for metabolism. Altogether, these results are consistent with the hypothesis that dopamine dehy-
droxylation can increase the fitness of metabolizing E. lenta strains in microbial communities.
Figure 2 continued
acetate. E. lenta was grown anaerobically for 48 hr at 37˚C. Dopamine, m-tyramine, and nitrate were added to a final concentration of 1 mM, while
DMSO was added to a final concentration of 14 mM at the time of inoculation. Tungstate (WO4
2–) and molybdate (MoO4
2–) were added to a final
concentration of 0.5 mM. Bars represent the mean ±the SEM of three biological replicates (bacterial cultures). The experiment was performed twice. (C)
Competition of dopamine metabolizing (Valencia) and non-metabolizing (W1BHI6) E. lenta strains in basal medium containing 10 mM acetate. Strains
were grown together for 72 hr at 37˚C and were then plated on BHI medium. Antibiotic resistance was used to determine strain identity. Bars represent
the mean ±the SEM of six biological replicates (bacterial cultures). (***p=0.0007, two-tailed unpaired t-test). The experiment was performed twice. (D)
Growth of defined gut bacterial consortia containing dopamine metabolizing and non-metabolizing E. lenta strains in basal medium containing 10 mM
acetate. Tetracycline resistant (TetR) E. lenta strains were grown with tetracycline sensitive (TetS) gut isolates for 48 hr at 37˚C. Plating on BHI medium
containing tetracycline allowed enumeration of E. lenta. Bars represent the mean ±the SEM of three biological replicates (bacterial cultures). The
experiment was performed twice. (E) Abundance of dadh in complex human gut communities cultured ex vivo. Samples from unrelated individuals
(n = 24) were grown for 72 hr at 37˚C in basal medium containing 10 mM acetate with or without dopamine and qPCR was used to assess abundance of
dadh. Two individuals were excluded from this analysis as they did not demonstrate quantitative metabolism of dopamine after incubation. Each point
represents a different individual. Lines connect data from the same individual between the two conditions. (***p=0.0005, two-tailed unpaired t-test,
n = 22 samples per group). The experiment was performed twice. (F) Counts of dadh variants in the presence and absence of dopamine. The same
gDNA used in E) was used to amplify full-length dadh and determine the SNP status at position 506 using Sanger sequencing. As in panel E, two
individuals were removed prior to analysis as they did not demonstrate quantitative metabolism of dopamine after incubation. In addition, one
individual was not included in this analysis due to failure of obtaining high quality sequencing data. (**p=0.008, Fisher’s exact test, n = 9 CGC samples
and n = 12 CGC/AGC samples for vehicle; n = 18 CGC samples and n = 3 CGC/AGC samples for dopamine). The sequencing was performed once. All
data , and details of the statistical tests, can be found in Figure 2—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Growth data from studies of impact of dopamine on E. lenta growth in basal medium lacking electron acceptors (Figure 2).
Figure supplement 1. Growth of E. lenta A2 in BHI medium with and without dopamine.
Figure supplement 2. Dehydroxylation of dopamine by E. lenta strains grown in in basal medium.
Figure supplement 3. Dose dependence of dopamine-promoted growth of E. lenta A2 in basal medium.
Figure supplement 4. Dehydroxylation of dopamine by E. lenta A2 in the presence of tungstate and molybdate in basal medium.
Figure supplement 5. Impact of tungstate and molybdate on E. lenta A2 growth in basal medium.
Figure supplement 6. CFU counts of E. lenta strains W1BHI6 and Valencia co-cultured in basal medium with and without dopamine.
Figure supplement 7. E. lenta qPCR abundance in human fecal samples cultured with and without dopamine ex vivo.
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A screen of human gut Actinobacteria uncovers dehydroxylation of
host- and plant-derived catechols
Having uncovered Dadh’s specialized role in gut bacterial dopamine metabolism, we sought to iden-
tify additional gut bacterial strains and enzymes that could dehydroxylate other catechol substrates.
Among human gut bacteria, only Eggerthella and closely related members of the Actinobacteria
phylum have been reported to perform catechol dehydroxylation. For example, Eggerthella metabo-
lizes dopamine (Maini Rekdal et al., 2019) and (+)-catechin (Takagaki and Nanjo, 2015), while
related Gordonibacter species dehydroxylate ellagic acid (Selma et al., 2014) and didemethylsecoi-
solariciresinol (dmSECO), an intermediate in the multi-step biosynthesis of the anti-cancer metabo-
lite enterodiol (Bess et al., 2020). These reports suggest that Actinobacteria could be a promising
starting point to identify new dehydroxylating strains and enzymes. Thus, we screened a library of
related gut Actinobacteria (Bisanz et al., 2018) (n = 3 replicates for each strain) for metabolism of a
range of compounds relevant in the human gut, including plant- and host-derived small molecules,
bacterial siderophores, and FDA-approved catecholic drugs (Wilson et al., 2016; Ozdal et al.,
2016; Yang et al., 2007) (Supplementary file 1e) (Figure 3A). We initially used a colorimetric assay
that detects catechols to assess metabolism, which allowed us to rapidly screen for potential cate-
chol depletion across the collection of 25 strains.
We observed complete depletion of several host and diet-derived catechols in this initial screen
(Figure 3—figure supplement 1). We chose to focus on the dehydroxylation of hydrocaffeic acid,
(+)-catechin, and DOPAC for further characterization, repeating the incubations with these com-
pounds and using LC-MS/MS to confirm the production of dehydroxylated metabolites. This analysis
showed that both DOPAC and hydrocaffeic acid are directly dehydroxylated by members of this
library, while (+)-catechin undergoes benzyl ether reduction followed by dehydroxylation into deriva-
tive 2, as has been observed previously (Takagaki and Nanjo, 2015) (Figure 3). While (+)-catechin
metabolism has been previously linked to Eggerthella (Takagaki and Nanjo, 2015), the dehydroxyla-
tion of DOPAC and hydrocaffeic acid has only been previously observed by complex gut microbiota
communities (Scheline et al., 1960; Peppercorn and Goldman, 1972). The variability in these activi-
ties across closely related gut bacterial strains suggests that distinct enzymes might dehydroxylate
different catechols.
Gut Actinobacteria dehydroxylate individual catechols using distinct
enzymes
We next sought to determine the molecular basis of the dehydroxylation reactions examined above.
To test the hypothesis specific rather than promiscuous enzymes were involved, we first established
that dehydroxylation is an inducible activity in Gordonibacter and Eggerthella strains (Figure 4—fig-
ure supplement 1). This allowed us to use the dehydroxylase activity of cell lysates as a proxy for
transcriptional induction and a means of examining dehydroxylase activity. We grew E. lenta A2 in
the presence of (+)-catechin, hydrocaffeic acid, and dopamine, and grew G. pamelaeae 3C in the
presence of DOPAC. We then screened each anaerobic lysate for its activity towards all of these
substrates. Consistent with our prediction, each lysate quantitively dehydroxylated only the catechol
substrate with which the strain had been grown. While the E. lenta lysates did not display any pro-
miscuity (Figure 4A), cell lysate from G. pamelaeae grown in the presence of DOPAC displayed
reduced activity (<45% conversion) towards hydrocaffeic acid, which structurally resembles DOPAC
(Figure 4B). Overall, these results suggest that different catechol substrates induce the expression
of distinct dehydroxylase enzymes that are specific in their activity and transcriptional regulation. We
expected that these enzymes would likely resemble Dadh, as only molybdenum-dependent enzymes
are known to catalyze aromatic dehydroxylation (Maini Rekdal et al., 2019; Hille et al., 2014;
Unciuleac et al., 2004).
To identify the molecular basis of (+)-catechin and hydrocaffeic acid dehydroxylation in E. lenta
A2, we turned to RNA-seq, the approach that we used previously to identify the dopamine dehy-
droxylase (Maini Rekdal et al., 2019). We grew E. lenta A2 to early exponential phase and then
added each catechol substrate, harvesting the cells after ~1.5 hr of induction. Hydrocaffeic acid and
(+)-catechin each upregulated a number of genes (21 and 43, respectively), including two predicted
molybdenum-dependent enzymes (Supplementary files 2a and 2b). While one of these predicted
molybdenum-dependent enzymes was among the highest upregulated genes in response to each
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Figure 3. Dehydroxylation of DOPAC, (+)-catechin, and hydrocaffeic acid by Gordonibacter pamelaeae 3C and Eggerthella lenta A2. (A-C) Pathways for
metabolism of (A) DOPAC, (B) (+)-catechin, (C) and hydrocaffeic acid by human gut Actinobacteria. While DOPAC and hydrocaffeic acid are
dehydroxylated directly, (+)-catechin metabolism proceeds by initial benzyl ether reduction followed by dehydroxylation of the catecholic derivative. (A)
Metabolism of DOPAC by G. pamelaeae 3C. This strain was grown in BHI medium with and without 1 mM DOPAC for 48 hr at 37˚C. Metabolism was
assessed using LC-MS/MS. Bars represent the mean ±the SEM concentration of the metabolite m-hydroxyphenylacetic acid (m-HPAA) resulting from
direct DOPAC dehydroxylation (three biological replicates, e.g. bacterial cultures). The experiment was performed twice. (B) (+)-catechin metabolism by
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substrate (450-fold upregulated in response to catechin, >2000 fold with hydrocaffeic acid), the
expression of the other enzyme was only increased 3-fold relative to the vehicle. Thus, we propose
that the most highly upregulated molybdenum-dependent enzyme in each dataset is the most rea-
sonable candidate dehydroxylase. The candidate hydrocaffeic acid dehydroxylase (Elenta-A2_02815,
named hcdh) shares 35.3% amino acid identity with Dadh, while the candidate (+)-catechin dehy-
droxylase (E. lenta-A2_00577, named cadh) shares 50.9% amino acid identity with Dadh
(Supplementary files 2a-2c).
To evaluate the involvement of a molybdenum enzyme in each dehydroxylation reaction, we cul-
tured the genetically intractable E. lenta A2 in the presence of tungstate (Maini Rekdal et al., 2019;
Rothery et al., 2008). As with dopamine dehydroxylation, tungstate inhibited dehydroxylation of
(+)-catechin and hydrocaffeic acid by E. lenta A2 without inhibiting growth in the rich BHI medium,
suggesting these activities are indeed molybdenum dependent (Figure 4—figure supplements 2
and 3). Tungstate did not inhibit benzyl ether reduction of (+)-catechin, indicating this step is likely
performed by a distinct enzyme (Figure 4—figure supplement 3). Finally, we found that the overall
distribution of the genes encoding these the putative hydrocaffeic acid and (+)-catechin dehydroxy-
lating enzymes across closely related Eggerthella strains correlated with metabolism of each sub-
strate (Figure 4C). For example, all Eggerthella strains except AN5LG harbored the putative
hydrocaffeic acid dehydroxylase and could dehydroxylate this substrate. Similarly, carriage of the
putative catechin dehydroxylase correlated with (+)-catechin metabolism, except for in the case of
strain AB12#2, which did not encode for the enzyme but still had low metabolism (<10%) (Figure 4C
and Figure 4—source data 1). This suggests that another enzyme might metabolize (+)-catechin in
this strain. Overall, these data suggest that Eggerthella uses distinct molybdenum-dependent
enzymes dehydroxylate hydrocaffeic acid and (+)-catechin.
We next sought to identify the enzyme responsible for DOPAC dehydroxylation in G. pamelaeae
3C. We added DOPAC to G. pamelaeae 3C cultures at mid-exponential phase and harvested cells
after 3 hr of induction when the cultures had reached early stationary phase. In this experiment, G.
pamelaeae 3C upregulated 100 different genes, including four distinct molybdenum-dependent
enzyme-encoding genes (Supplementary file 2d). One of these genes (C1877_13905) was among
the highest upregulated genes across the dataset (>1700 fold induced). To further explore the asso-
ciation between this gene and DOPAC dehydroxylation, we repeated the RNA-seq experiment,
growing G. pamelaeae 3C in the presence of DOPAC from the time of inoculation and then harvest-
ing cells in mid-exponential phase as soon we could detect metabolism (12 hr of growth). In this
experiment, the same molybdenum-dependent enzyme-encoding gene (C1877_13905) that was
highly upregulated in our first experiment (Supplementary file 2e) was among the highest upregu-
lated genes. The only two other molybdenum-dependent enzymes induced in this experiment were
expressed at an order of magnitude lower levels (<2.5-fold induced). We propose that the molybde-
num-dependent enzyme encoded by C1877_13905 is a likely candidate DOPAC dehydroxylase.
This assignment is also supported by comparative genomics. First, carriage of C1877_13905
(named dodh) correlated with DOPAC dehydroxylation among members of our gut Actinobacterial
library (Figure 4C). Consistent with our lysate assays, those organisms harboring this gene also had
activity towards hydrocaffeic acid, which could explain the pattern of hydrocaffeic acid metabolism
across the gut Actinobacterial library (Figure 4C). Finally, the functionally annotated gene most
Figure 3 continued
E. lenta A2. This strain was grown in BHI medium with and without 1 mM (+)-catechin for 48 hr at 37˚C. Metabolism was assessed using high resolution
LC-MS. Bars represent the mean ±the SEM mass peak area of the Extracted Ion Chromatogram (EIC) for the dehydroxylated derivative 2 shown above
the bar graph in B) (three biological replicates, e.g. bacterial cultures). Due to the absence of an authentic standard, integrated peak area of the high-
resolution mass is displayed. The experiment was performed twice. C) Metabolism of hydrocaffeic acid by E. lenta A2. This strain was grown in BHI
medium with and without 1 mM hydrocaffeic acid for 48 hr at 37˚C. Metabolism was assessed using LC-MS/MS. Bars represent the mean ±the SEM
concentration of m-hydroxyphenylpropionic acid (m-HPPA) resulting from the direct dehydroxylation of hydrocaffeic acid (three biological replicates,
e.g. bacterial cultures). The experiment was performed twice. All data can be found in Figure 3—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Metabolism data from incubations of G. pamelaeae 3C with DOPAC and from E. lenta A2 with hydrocaffeic acid and (+)-
catechin (Figure 3).
Figure supplement 1. Colorimetric screen for catechol dehydroxylation by human gut Actinobacteria.
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 10 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
E.
 
le
n
ta
 
A2
 
gr
o
w
n
 
w
ith
A
Ve
hi
cl
e
D
op
am
in
e
H
yd
ro
ca
ffe
ic 
ac
id
(+)
-C
ate
ch
in
D
O
PA
C 
Vehicle
Dopamine
Hydrocaffeic acid 
(+)-Catechin
Substrate added to lysate
100
Ve
hi
cl
e
D
op
am
in
e
H
yd
ro
ca
ffe
ic 
ac
id
(+)
-C
ate
ch
in
D
O
PA
C 
Vehicle
DOPAC 
G
.
 
pa
n
m
el
ae
ae
 
3C
 
gr
o
w
n
 
w
ith
B
Substrate added to lysate
080 60 40 20
% conversion
100 080 60 40 20
% conversion
hcdh cadh dodh
Gene presence
Dehydroxylation detected by LC-MS?
YES NO
C
D
m-Hydroxyphenylpropionic acid 
(m-HPPA) MRM m/z 165->121
Hydrocaffeic acid 
MRM m/z 181->137
Hy
dro
ca
ffe
ic a
cid
Do
pa
mi
ne
DO
PA
C
(+)-
cat
ech
in
0
50
100
Substrate
%
 
De
hy
dr
o
x
yl
at
io
nE
HO
HO
O
OH
HO
O
OH
El Valencia
El DSM 15644
El RC4/6F
El AB12 #2
El AN51LG
El DSM 11863
El A2
El CC8/2 BHI2
El AB8 #2
El F????????
El 22C
El CC8/6 D5 4
El MR1 #12
El CC7/5 D5 2
El W1 BHI 6
Es DSM 16107
Ph RC2/2 A
Gp 3C
Gs 28C
El 28B
El DSM 2243
El 11C
El 14A
El F????????AU
???????????????
El DSM 11767
Hy
dro
ca
ffe
ic
 
ac
id (+)-
cat
ech
in 
DO
PA
C
Time (minutes)
32 4 51 6
Time (minutes)
32 4 51 6
Hcdh -Hydrocaffeic acid
m-HPPA standard 
Hcdh +Hydrocaffeic acid +O2
Hcdh +Hydrocaffeic acid
Hydrocaffeic acid standard
Hcdh -Hydrocaffeic acid
m-HPPA standard 
Hcdh +Hydrocaffeic acid +O2
Hcdh +Hydrocaffeic acid
Hydrocaffeic acid standard
Hy
dro
ca
ffe
ic a
cid
 + 
O 2
Figure 4. Gut Actinobacteria dehydroxylate individual catechols using distinct enzymes. (A) Specificity of dehydroxylase regulation and activity in E.
lenta A2. E. lenta A2 was grown anaerobically in BHI medium containing 1% arginine and 10 mM formate. 0.5 mM of catechol was added to induce
dehydroxylase expression, followed by anaerobic lysis and enzyme assays. Crude lysates were exposed to different substrates (500 mM) and reactions
were allowed to proceed anaerobically for 20 hr. Assays mixtures were analyzed using LC-MS. Heat map represents the mean of three biological
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similar to the candidate DOPAC dehydroxylase is Cldh (45% amino acid ID), a Gordonibacter
enzyme recently implicated in the dehydroxylation of the lignan dmSECO (Bess et al., 2020)
(Supplementary file 2c). Though this functional assignment awaits biochemical confirmation, we
propose that the highest upregulated enzyme across our two independent datasets is the DOPAC
dehydroxylase. Interestingly, unlike with the Eggerthella dehydroxylases, tungstate did not inhibit
dehydroxylation of DOPAC by G. pamelaeae (Figure 4—figure supplement 3). This may be
explained if the dehydroxylating enzyme can use both molybdenum and tungsten for catalysis, as is
seen in certain closely related enzymes (Rosner and Schink, 1995).
To biochemically validate one of our candidate dehydroxylases, we adapted the native purifica-
tion protocol used for Dadh to fractionate the hydrocaffeic acid dehydroxylase activity from E. lenta
A2 cell lysates. This yielded an active fraction that contained five major bands as assessed by SDS-
PAGE (Figure 4—figure supplement 4) and quantitatively dehydroxylated hydrocaffeic acid into m-
hydroxyphenylacetic acid under anaerobic conditions (Figure 4D). We confirmed that the band with
the apparent correct size (Figure 4—figure supplement 4) contained the proposed hydrocaffeic
acid dehydroxylase (Hcdh, Elenta-A2_02815) (Figure 4—figure supplement 5 and
Supplementary file 2f) using proteomics. We also performed an additional set of enzyme assays
using this preparation to evaluate the substrate scope of Hcdh. Consistent with our experiments in
cell lysates (Figure 4A), we observed dehydroxylation only of hydrocaffeic acid and not of dopa-
mine, (+)-catechin, or DOPAC (Figure 4E). These data biochemically link the newly identified hcdh
gene to hydrocaffeic acid dehydroxylation, further supporting the proposal that different enzymes
dehydroxylate distinct catechol substrates.
Despite being expected to perform the same type of chemical reaction, the putative catechol
dehydroxylases from E. lenta and G. pamelaeae differ in sequence identity, genomic context, and
predicted subunit composition (Supplementary file 3a and Figure 4—figure supplement 6). The
dopamine, catechin and hydrocaffeic acid dehydroxylases from E. lenta (dadh, cadh and hcdh,
respectively) are likely membrane-bound complexes as they co-localize with genes encoding an
Figure 4 continued
replicates (lysate reactions). The experiment was performed twice. (B) Specificity of DOPAC dehydroxylase regulation and activity in G. pamelaeae A2.
G. pamelaeae 3C was grown anaerobically in BHI medium containing 10 mM formate. 0.5 mM of catechol was added to induce dehydroxylase
expression, followed by anaerobic lysis and enzyme assays. Crude lysates were exposed to different substrates (500 mM) and reactions were allowed to
proceed anaerobically for 20 hr. Assays mixtures were analyzed using LC-MS. Heat map represents the mean of three biological replicates (lysate
reactions). The experiment was performed twice. (C) Distribution of putative catechol dehydroxylases and their associated metabolic activities across
the gut Actinobacterial library used in our study. The tree represents the phylogeny of gut Actinobacterial strains adapted from Koppel et al. (2018).
El = Eggerthella lenta, Es = Eggerthella sinesis, Ph = Paraggerthella, Gs = Gordonibacter sp., Gp = Gordonibacter pamelaeae. Squares represent gene
presence/absence of select dehydroxylases across gut Actinobacterial strains (90% coverage, 75% amino acid identity cutoff, e-value = 0). To evaluate
catechol metabolism, individual strains were grown in triplicate in the presence of a single catechol substrate for 48 hr at 37˚C in BHI medium.
Metabolism was assessed using LC-MS/MS. A red dot indicates that the mass of the dehydroxylated product was detected in cultures from this strain,
while a black dot indicates lack of metabolism. The experiment was performed once. (D) In vitro activity of Hcdh-containing fractions purified from E.
lenta A2. EICs for detection of hydrocaffeic acid (MRM m/z 181- > 137) and m-hydroxyphenylpropionic acid (m-HPPA) (MRM m/z 165- > 121) after 26 hr
of anaerobic incubation of enzyme preparation with 500 mM hydrocaffeic acid, 500 mM methyl viologen, and 1 mM sodium dithionite at room
temperature. Peak heights show the relative intensity of each mass, and all chromatograms are shown on the same scale. The experiment was
performed under anaerobic conditions unless otherwise indicated. The experiment was performed once. (E) Substrate scope of Hcdh-containing
fractions purified from E. lenta A2. The enzyme preparation used in D) was diluted 1:5 in buffer and was incubated with 500 mM catechol substrate, 500
mM methyl viologen, and 1 mM sodium dithionite at room temperature for 26 hr under anaerobic conditions. The enzyme reactions were analyzed by
LC-MS/MS. Bars represent the mean ±the SEM of three independent enzyme reactions. The experiment was performed once. All data can be found in
Figure 4—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Data from lysate assays in E. lenta A2 and G. pamelaeae 3C, screening of Actinobacterial library for metabolism of DOPAC, hydrocaffeic
acid, and (+)-catechin, and enzyme assays with hydrocaffeic acid dehydroxylase (Figure 4).
Figure supplement 1. Inducibility and oxygen sensitivity of catechol dehydroxylation by whole cell suspensions of E. lenta A2 and G. pamelaeae 3C.
Figure supplement 2. Impact of tungstate on E. lenta A2 growth in BHI medium.
Figure supplement 3. Impact of tungstate on catechol metabolism by E. lenta A2 and G. pamelaeae 3C.
Figure supplement 4. SDS-PAGE of partially purified hydrocaffeic acid dehydroxylase from E. lenta A2.
Figure supplement 5. Peptide coverage of the hydrocaffeic acid dehydroxylase from E. lenta A2 from proteomics.
Figure supplement 6. Genomic contexts and predicted subunit composition of Gordonibacter and E. lenta dehydroxylases.
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electron shuttling 4Fe-4S ferredoxin and a putative membrane anchor (Figure 4—figure supple-
ment 6) (Rothery et al., 2008; Rothery and Weiner, 2015). These enzymes all carry a Twin-Argi-
nine-Translocation (TAT) signal sequence, suggesting they are exported from the cytoplasm before
the signal sequence is cleaved off. We found no peptide coverage of the TAT signal sequence in the
proteomics experiment that identified E. lenta Hcdh, further confirming that this sequence is cleaved
in the mature protein as in other membrane-anchored moco enzymes (Figure 4—figure supplement
5) (Iobbi-Nivol and Leimku¨hler, 2013). In contrast, dodh and similar enzymes from G. pamelaeae
do not harbor a TAT signal sequence, are smaller than the E. lenta enzymes, and co-localize with a
gene predicted to encode a small electron shuttling 4Fe-4S protein, suggesting they are likely solu-
ble protein complexes (Figure 4—figure supplement 6). These putative G. pamelaeae dehydroxy-
lases are also encoded adjacent to members of the Major Facilitator Superfamily, transporters that
may import or export the catechol substrates or dehydroxylated metabolites (Figure 4—figure sup-
plement 6). Altogether, these data indicate the existence of distinct subtypes of molybdenum-
dependent catechol dehydroxylases.
Catechol dehydroxylases are variably distributed in metagenomes and
correlate with metabolism by complex gut microbiota samples ex vivo
Our finding that catechol dehydroxylases and their associated metabolic activities are variably dis-
tributed among closely related gut Actinobacteria made us wonder whether human gut microbial
communities would harbor similar genetic and metabolic diversity. To address this, we first
searched >1800 publicly available human gut metagenomes (Nayfach et al., 2015) for dadh, hcdh,
cadh, dodh, and the recently identified cldh (Bess et al., 2020) genes. Although found at generally
low abundances, these catechol dehydroxylases were widely but variably distributed across these
metagenomes. Dadh and hcdh were the most prevalent (in >70% and>90% of individuals, respec-
tively), followed by cadh (30%), dodh (20%), and cldh (25%) (Figure 5A). Notably, the prevalence of
the different genes in metagenomes is consistent with their distribution among individual human gut
Actinobacterial isolates (Figure 4C).
To assess the presence of catechol dehydroxylation in complex gut microbiotas, we incubated
fecal samples from unrelated humans (n = 12) ex vivo with hydrocaffeic acid, (+)-catechin, and sta-
ble-isotope deuterium-labeled dopamine and DOPAC and analyzed dehydroxylation by LC-MS/MS.
In this experiment, we observed dehydroxylation of dopamine, hydrocaffeic acid, and DOPAC across
the majority of subjects, indicating that metabolic activities of low-abundance gut Actinobacteria are
indeed prevalent (Figure 5B–D). However, catechol metabolism varied between compounds and
subjects, with some individuals metabolizing all compounds and some metabolizing none
(Figure 5B–D). (+)-Catechin was depleted without production of the corresponding dehydroxylated
metabolites, consistent with this compound undergoing a wide range of metabolic reactions in com-
plex communities (Figure 5—source data 1) (Takagaki and Nanjo, 2013; van’t Slot and Humpf,
2009; Aura et al., 2008).
To investigate whether metabolic variability correlated with the presence of specific dehydroxy-
lase enzymes, we further investigated DOPAC metabolism. We separated the 12 samples into a
group of 9 metabolizers and three non-metabolizers (in which no biological replicate displayed dehy-
droxylation activity). qPCR enumeration in these cultures revealed that the abundance of the candi-
date DOPAC dehydroxylase gene dodh discriminated metabolizing and nonmetabolizing subjects
(p<0.001, unpaired t-test) (Figure 4E), and correlated significantly with dehydroxylation activity
within the nine metabolizers (Pearson’s correlation, r = 0.73, R2 = 0.53, p<0.05) (Figure 4F). Alto-
gether, these data are consistent with our previous finding that dadh SNP status correlates with
dopamine metabolism in human gut microbiotas ex vivo (Maini Rekdal et al., 2019) and suggest
that the candidate dehydroxylases may be active in complex gut communities.
Catechol dehydroxylases are distinct from other molybdenum-
dependent enzymes and are widely distributed across sequenced
microbes
We next investigated the relationship of catechol dehydroxylases to other characterized molybde-
num-dependent enzymes. These enzymes bear no sequence homology to the only other biochemi-
cally characterized aromatic dehydroxylase, 4-HCBR; whereas 4-HCBR belongs to the xanthine
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Figure 5. Catechol dehydroxylases are variably distributed in human gut metagenomes and correlate with metabolism by complex gut microbiota
samples ex vivo. (A) Prevalence estimates (%) as a function of minimum abundance reveals that the candidate dehydroxylases are variably distributed
but prevalent in human gut metagenome samples at low relative abundances. B-D) Metabolism of d4-dopamine (B), hydrocaffeic acid (C), and d5-
DOPAC (D) by 12 unrelated human gut microbiota samples ex vivo. Samples were cultured anaerobically in BHI medium with 500 mM substrate for 72
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oxidase family of molybdenum-dependent enzymes, the catechol dehydroxylases belong to the bis-
MGD family of molybdenum-dependent enzymes, suggesting independent evolutionary origins
(Hille et al., 2014; Unciuleac et al., 2004; Tenbrink et al., 2011). Further phylogenetic analysis
revealed that catechol dehydroxylases form a unique clade within the bis-MGD enzyme family, clus-
tering away from pyrogallol hydroxytransferase (Pht), the only other bis-MGD enzyme known to
modify the aromatic ring of a substrate (Messerschmidt et al., 2004) (Figure 6 and
Supplementary file 3b). The catechol dehydroxylases are instead most closely related to acetylene
hydratase, an enzyme that adds water to acetylene to provide a carbon source for the marine Pro-
teobacterium Pelobacter acetylenicus (Figure 6) (Tenbrink et al., 2011; Rosner and Schink, 1995;
Schoepp-Cothenet et al., 2012). A sequence similarity network (SSN) analysis using sequences of
bis-MGD enzymes revealed distinct clusters of catechol dehydroxylases, further suggesting these
enzymes are functionally different from known family members (Figure 7—figure supplement 1).
The clustering of the dehydroxylases in the SSN did not simply reflect the phylogeny of the organ-
isms because additional sequences from both Eggerthella and Gordonibacter were found in clusters
containing distinct, biochemically characterized enzymes (Figure 7—figure supplement 2). In addi-
tion, we found that the two catechol dehydroxylase-containing clusters also harbored sequences
from organisms other than Eggerthella and Gordonibacter (Figure 7—figure supplement 2). Based
on these data, we propose that catechol dehydroxylases are a distinct group of molybdenum-depen-
dent enzymes.
To assess the diversity of putative dehydroxylases, we queried the NCBI nucleotide database and
our collection of Actinobacterial genomes for homologs of the Eggerthella and Gordonibacter
enzymes. Phylogenetic analyses of the resulting sequences revealed a large diversity of putative
dehydroxylases, including numerous uncharacterized enzymes encoded in individual Gordonibacter
and Eggerthella genomes (Figure 7). This highlights that catechol dehydroxylases likely have diversi-
fied within these closely related gut Actinobacteria, that individual gut Actinobacteria can likely
metabolize a range of different catechols, and that many substrate-enzyme pairs remain to be dis-
covered. Our analysis also revealed that catechol dehydroxylases are not restricted to human-associ-
ated Actinobacteria and are instead part of a larger group of bis-MGD enzymes present in diverse
bacteria and even Archaea (Figure 7). These organisms come from mammal-associated, plant-asso-
ciated, soil, and aquatic habitats. Notable organisms encoding putative dehydroxylases include soil-
dwelling Streptomycetes (Wu et al., 2017; Huang et al., 2012), the industrially important anaerobe
Clostridium ljungdahlii (Ko¨pke et al., 2010), and a large number of anaerobic bacterial genera
known for their ability to degrade aromatic compounds, including Azoarcus, Thauera, Desulfobacula,
Geobacter, Desulfumonile, and Desulfitobacterium (Figure 7) (DeWeerd et al., 1991;
Wo¨hlbrand et al., 2013; Butler et al., 2007; Wagner et al., 2012; Cole et al., 1995;
Ferna´ndez et al., 2014; Molina-Fuentes et al., 2015; Villemur et al., 2006; Pacheco-
Sa´nchez et al., 2019a). The presence of similar enzymes in gut and environmental microbes likely
reflects the availability of catechol substrates in many different environments (Figure 7).
As the vast majority of dehydroxylase homologs remain uncharacterized, it is difficult to assign
the biochemical activities of the major clades and define the characteristic features of these
enzymes. However, we are confident that at least some portion of the sequences captured in this
analysis are true catechol dehydroxylases. First, we found that representative sequences from across
our phylogenetic tree are more closely related to acetylene hydratase and the Gordonibacter and
Figure 5 continued
hr and metabolism was analyzed by LC-MS/MS. Bars are mean % dehydroxylation ± SEM (n = 3 independent cultures for each fecal sample).
Metabolizing E. lenta A2 or G. pamelaeae 3C strains were included as positive controls. The experiment was performed once. (E) The abundance of
dodh correlates with DOPAC dehydroxylation in human gut microbiota samples. Data represent the average dodh abundance (as assessed with qPCR)
across the three replicates for samples in (D). Results are mean abundance ± SEM (***p<0.001, two-tailed t- test). (F) The abundance of dodh among
metabolizers correlates with DOPAC dehydroxylation. The data plotted represent the average dodh abundance (as assessed with qPCR) and the
average % dehydroxylation across the three replicates for metabolizing samples in (D) (all samples except 6,7, and 12). The line represents the best-fit
trendline for linear regression. There was a significant linear correlation between dodh abundance and % DOPAC dehydroxylation (Pearson’s
correlation, r = 0.73, R2 = 0.53, p<0.05). All data can be found in Figure 5—source data 1.
The online version of this article includes the following source data for figure 5:
Source data 1. Data from incubations of human fecal samples with catechols (Figure 5).
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Eggerthella dehydroxylases than to any other member of the bis-MGD enzyme family, indicating
shared evolutionary origins (Supplementary file 3c and Figure 7—figure supplements 3 and
4). Moreover, recent genetic studies have implicated several homologs from environmental bacteria
in catechol dehydroxylation. For instance, a putative dehydroxylase is present in Streptomyces bio-
synthetic gene clusters that produce the potent anti-tumor compounds yatakemycin and CC-1065
(Wu et al., 2017; Huang et al., 2012) (Figure 7). Gene knock-out and complementation studies
revealed this enzyme is essential for CC-1065 production and likely catalyzes reductive dehydroxyla-
tion of a late-stage biosynthetic intermediate (Wu et al., 2017). Another homolog is present in the
3,5-dihydroxybenzoate (3,5-DHB) degradation operon within the anaerobic soil Proteobacterium
Tree scale: 1
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Figure 6. Catechol dehydroxylases are distinct from other molybdenum-dependent enzymes. Phylogenetic analysis of newly discovered catechol
dehydroxylases reveals a unique evolutionary origin and relationship to acetylene hydratase. Psr = polysulfide reductase; Arr = arsenate reductase;
Fdh = formate dehydrogenase; Pht = phloroglucinol transhydroxylase; Dms = DMSO reductase; Tmr = TMAO reductase; Aro = arsenite oxidase;
Ebd = ethylbenzene dehydrogenase; Pcr = perchlorate reductase; Nar = nitrate reductase; Cdh = catechol dehydroxylase. The maximum likelihood
tree was constructed using sequences from Schoepp-Cothenet et al. (2012) as well as additional family members and reproduced the previously
reported phylogeny of this enzyme family. Black circles on branches indicate bootstrap values greater than 0.7. Alignment and tree files can be found in
Figure 6 alignment.fasta and Figure 6 tree file.nex, respectively.
The online version of this article includes the following source data for figure 6:
Source data 1. Alignment file for bis-MGD family tree (Figure 6).
Source data 2. Tree file for bis-MGD family tree (Figure 6).
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Figure 7. Catechol dehydroxylases are widely distributed across sequenced microbes. Maximum likelihood phylogenetic tree for catechol
dehydroxylase homologs identified by querying 26 gut Actinobacterial genomes (Bisanz et al., 2018) and the NCBI nucleotide collection for Dadh and
Cldh homologs (see Materials and methods for details). The color of the lines indicates the phylogeny of the organism harboring the homolog. The
color of the border indicates the primary habitat from which the organism was originally isolated. Numbers at the end of the branches indicate
Figure 7 continued on next page
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 17 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
Thaeura aromatica (Figure 7). Strains lacking this enzyme exhibit impaired growth on 3,5-DHB as a
sole carbon source, suggesting a possible role for this enzyme in metabolizing the one of the two
catecholic intermediates involved in this pathway (Molina-Fuentes et al., 2015; Pacheco-
Sa´nchez et al., 2019a; Pacheco-Sa´nchez et al., 2019b). Based on this analysis, we conclude that
the catechol dehydroxylases harbor vast uncharacterized diversity that contributes to both primary
and secondary metabolic pathways in habitats beyond the human gut.
Catechol dehydroxylase reactivity is present across the gut microbiotas
of mammals representing distinct diets and phylogenetic origins
Our phylogenetic analysis suggested that catechol dehydroxylase activity is present in a range of
microbial habitats, making us curious whether we could detect this metabolism in additional micro-
bial communities. As a first step, we explored catechol dehydroxylation by gut microbiotas of non-
human mammals. We assembled a panel of gut microbiota samples from 12 different mammals rep-
resenting diverse phylogenetic origins and diets (three individuals per mammal) (Reese et al., 2018;
Reese et al., 2019) (Figure 8 and Figure 8—figure supplement 1). We cultured these gut commu-
nities anaerobically ex vivo, assessed metabolism using a colorimetric assay, and confirmed potential
hits using LC-MS/MS (Figure 8—figure supplement 1). We observed catechol dehydroxylation
across the gut microbiotas of mammals spanning different diets and phylogenies (Figure 8). Hydro-
caffeic acid dehydroxylation occurred in >50% of species, while dopamine and (+)-catechin metabo-
lism were observed in 5/12 and 4/12 animals, respectively (Figure 8). DOPAC was only metabolized
by the rat gut microbiota, which was the only community that had activity towards all compounds
tested. While a larger sample size is required to reach clear conclusions about possible links between
metabolism of specific catechols and individual mammal gut microbiotas, our results clearly demon-
strate that catechol dehydroxylation is found in distantly related mammal gut microbiotas that have
large differences in species composition and gene content (Reese et al., 2018; Reese et al., 2019;
Coelho et al., 2018). This finding further reinforces the relevance of catechol dehydroxylation to
variety of different microbial habitats.
Discussion
For many decades the human gut microbiota has been known to dehydroxylate catechols, but the
molecular basis of this enigmatic transformation has remained largely unknown. In this study, we
characterized the specificity and regulation of a gut bacterial enzyme that dehydroxylates dopamine
(Dadh). We then used this knowledge to identify candidate enzymes that dehydroxylate additional
host-and plant-derived small molecules. Together, the catechol dehydroxylases represent a previ-
ously unappreciated group of molybdenum-dependent enzymes that is present in diverse microbial
phyla and environments. Our studies of Dadh revealed a high specificity for catecholamines, sup-
porting the hypothesis that the physiological role of this enzyme is to enable neurotransmitter
metabolism by E. lenta. This idea is also consistent with recent observations of gut bacteria using
Figure 7 continued
highlighted sequences, which are specified in the legend above. Unchar. stands for uncharacterized. The color of the organism matches the phylogeny
of the organism. DMSO reductase from E. coli (sequence #15) was used as an outgroup to root the tree. All of the sequences highlighted in the figure
in the figure are mentioned in the main text. Black circles on branches indicate bootstrap values greater than 0.7. Alignment and tree files can be found
in Figure 7 alignment.fasta and Figure 7 tree file.newick, respectively.
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Source data 1. Alignment file for tree displaying catechol dehydroxylase diversity and distributionamong sequenced microbes (Figure 7).
Source data 2. Tree file for tree displaying catechol dehydroxylase diversity and distribution among sequenced microbes (Figure 7).
Figure supplement 1. Sequence similarity network of the bis-MGD enzyme family reveals that the Gordonibacter and Eggerthella dehydroxylases
belong to distinct, uncharacterized clusters.
Figure supplement 2. Sequence similarity network of the bis-MGD enzyme family reveals that Gordonibacter and Eggerthella bis-MGD enzymes are
widely distributed across the enzyme family.
Figure supplement 3. Phylogenetic analysis of representative catechol dehydroxylase homologs highlighting sequences included in further analyses.
Figure supplement 4. Phylogenetic analysis of putative catechol dehydroxylase sequences from diverse bacterial phyla reveals a relationship with the
biochemically characterized molybdenum-dependent enzyme acetylene hydratase.
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specific neurotransmitters for growth (Strandwitz et al., 2019). To our knowledge, Dadh is the first
catecholamine-metabolizing enzyme from a human gut commensal. However, interactions between
catecholamines and intestinal pathogens are well-characterized and have long been known as key
players in virulence and infection (Freestone et al., 2007; Lyte and Ernst, 1992). Whereas patho-
genic organisms such as Escherichia coli, Yersinia enterocolitica, and Salmonella enterica require the
intact catechol group of dopamine and norepinephrine to sequester iron and boost growth
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Figure 8. Gut microbiotas of mammals representing distinct diets and phylogenetic origins can dehydroxylate catechols. Catechol dehydroxylation of
dopamine, DOPAC, (+)-catechin, and hydrocaffeic acid by gut microbiota samples from mammals spanning distinct diets and phylogenetic groups. Gut
communities from 12 different mammals and three individuals per animal were cultured anaerobically for 96 hr in basal medium with 0.5 mM catechol
at 37˚C. The results summarize animals and individuals where the known dehydroxylation pathways examined in human gut Actinobacteria took place,
as assessed by LC-MS/MS. Red indicates that metabolism took place in at least one of the individuals, and black indicates lack of metabolism, as
assessed by the detection of the dehydroxylated metabolite using LC-MS/MS. The experiment was performed once. The phylogenetic tree was created
using the aptg plugin in R and missing branches were added manually based on mammalian phylogeny. The icons were adapted under a Creative
Commons license (https://creativecommons.org/licenses/by/3.0/) at phylopic (http://phylopic.org), including Alpaca logo (made my Steven Traver),
Bison (Lukasiniho). Cow (Steven Traver), Dog (Tracy A Heath), Fox (Anthony Caravaggi), Guinea pig (Zimices), Mouse (Madeleine Price Ball), Pig (Steven
Traver), Rabbit (Steven Traver), Rabbit (Steven Traver), Rat (Rebecca Groom), Sheep (Zimices), and Wolf (Tracy A Heath). All data can be found in
Figure 8—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 8:
Source data 1. Screen for catechol metbabolism by mammalian gut microbiota samples (Figure 8).
Figure supplement 1. Screen for catechol dehydroxylation by gut microbiota samples from diverse mammals.
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(Freestone et al., 2007; Lyte and Ernst, 1992; Rooks et al., 2017; Dichtl et al., 2019), we propose
that E. lenta uses these molecules as electron acceptors. Thus, Dadh might represent a novel strat-
egy by which gut bacteria take advantage of catecholamines present in the gastrointestinal tract
(Eisenhofer et al., 1997; Eisenhofer et al., 1996). Understanding the interplay between pathogenic
and commensal interactions with catecholamines is an intriguing avenue for further research.
In addition to characterizing Dadh, we discovered candidate dehydroxylases that metabolize (+)-
catechin, hydrocaffeic acid, and DOPAC. We also partially purified the hydrocaffeic acid dehydroxy-
lase to confirm its involvement in this reaction. Further biochemical studies are important for validat-
ing the activities of the remaining enzymes, but our preliminary data support a working model in
which catechol dehydroxylation is performed by distinct enzymes that are specialized for individual
substrates. We identified large numbers of uncharacterized dehydroxylases encoded within individ-
ual Eggerthella and Gordonibacter genomes (Figure 7), hinting at an expansion of this group of
enzymes among human gut Actinobacteria. While it remains to be seen whether these uncharacter-
ized enzymes are also specific for distinct substrates, this type of diversification of closely related
enzymes indicates a potentially important role for catechol dehydroxylation in the human gut micro-
biota. Expansion of enzyme families within specific clades of gut microbes is well-characterized in
the context of polysaccharide metabolism. For example, individual human gut Bacteroides strains
isolates harbor hundreds of polysaccharide utilization loci but upregulate only a subset of genes in
response to distinct substrates (Martens et al., 2011; Rogowski et al., 2015; Ndeh et al., 2017;
Larsbrink et al., 2014). This transcriptional regulation and biochemical specificity enables utilization
of various host- or plant-derived carbon sources depending on their availability (Hehemann et al.,
2010; Desai et al., 2016; Sonnenburg et al., 2010). The diversity of catechol dehydroxylases might
have evolved in a similar manner, providing a biochemical arsenal that enables Actinobacteria to use
a range of different electron acceptors whose availability depends on the diet and/or physiology of
the host. Identifying the substrates of uncharacterized catechol dehydroxylases could shed light on
the adaptation of gut organisms to small molecules produced and ingested by the host.
In addition to uncovering the diversity of catechol dehydroxylases, our study illustrates that the
chemical strategies used to enable microbial survival and interactions in the human gut may be rele-
vant to a broad range of species and habitats. While mammalian gut microbiomes have previously
been compared in terms of gene content and species composition (Reese et al., 2019;
Coelho et al., 2018; Youngblut et al., 2019), our study provides functional evidence for conserva-
tion of specific gut microbial metabolic pathways across distinct hosts. While this hints at potentially
important roles for catechol dehydroxylation across mammalian gut communities, the distribution of
putative dehydroxylases among environmental microbes suggests this chemistry is present in many
additional microbial habitats. This reinforces findings from studies of additional gut microbial
enzymes. For example, gut microbial carbohydrate-degrading enzymes and glycyl radical enzymes,
which play important roles in degrading diet-derived polysaccharides, amino acids, and osmolytes in
the human gut, are also found in environmental isolates (Ndeh et al., 2017; Levin et al., 2017;
Craciun and Balskus, 2012; Peck et al., 2019). Enzyme discovery in the human gut microbiota not
only has implications for improving human health and disease, but also for discovering novel catalytic
functions and metabolic pathways broadly relevant to microbial life. Our study now sets the stage
for further investigations of the chemical mechanisms and biological consequences of catechol dehy-
droxylation in the human body and beyond.
More broadly, our study underscores how enzyme discovery can help to dissect the metabolic
diversity of gut microbial strains and communities. Although previous studies had linked certain
dehydroxylation reactions to individual gut Actinobacteria (Maini Rekdal et al., 2019; Takagaki and
Nanjo, 2015; Selma et al., 2014; Bess et al., 2020), we have found that specific catechol dehydrox-
ylases are variably distributed among closely related strains and human gut metagenomes. These
findings reinforce the idea that gut microbial phylogeny is often not predictive of functional capabili-
ties (Koppel et al., 2018; Maini Rekdal et al., 2019; Levin et al., 2017; Craciun and Balskus, 2012;
Peck et al., 2019; Martı´nez-del Campo et al., 2015). Additionally, we noticed that the prevalence
of the different dehydroxylation reactions among human and animal gut microbiota samples
reflected their distribution among individual Actinobacterial strains, with hydrocaffeic acid metabo-
lism being the most prevalent across all strains and species, and DOPAC dehydroxylation being the
least prevalent. This may suggest that the strain-level variability in dehydroxylases is important for
metabolism both within humans and other mammalian species. While the evolutionary forces
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shaping the distribution of specific dehydroxylases within gut bacterial strains and complex gut com-
munities remain unknown, our data provide a starting point for further understanding the effects of
catechol dehydroxylation on both gut microbiota and host.
Finally, our findings provide a framework for linking metabolic transformations performed by
complex gut microbial communities to individual strains, genes, and enzymes. Our broad exploration
of a class of metabolic transformations contrasts with the more common focus on metabolism of
individual drugs or dietary compounds (Maini Rekdal et al., 2019; Koppel et al., 2018; Levin et al.,
2017; Craciun and Balskus, 2012; Peck et al., 2019; Martı´nez-del Campo et al., 2015;
Williams et al., 2014; Yan et al., 2018). This functional group-focused approach may greatly
increase the efficiency with which we can link metabolic activities to microbial genes and enzymes.
We envision that related experimental workflows could find broad utility in the discovery of gut
microbial enzymes catalyzing other widespread, biologically significant reactions, including reductive
metabolism of additional functional groups that are prevalent in diverse molecules encountered by
the gut microbiota (Koppel et al., 2017).
Materials and methods
This section includes the key resources table and materials, methods, and data for all experiments
except for synthesis and characterization of dopamine. Materials, methods, and characterization
data for synthesis of dopamine analogs can be found Appendix 1.
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Eggerthella lenta)
Eggerthella
lenta strains
REF 37 El See Supplementary file 1d
Strain, strain
background
(Eggerthella sinensis)
Eggerthella
sinensis DSM16107
REF 37 Es See Supplementary file 1d
Strain, strain
background
(Gordonibacter)
Gordonibactr
strains
REF 37 Gp, Gs See Supplementary file 1d
Strain, strain
background
(Paraeggerthella)
Paraeggerthella
hongkongensis
REF 37 Ph See Supplementary file 1d
Strain, strain
background
(Eschericia coli)
Eschericia coli
MG1655
Palmer lab,
Newcastle University
See Supplementary file 1d
Strain, strain
background (Bacteroides
fragilis ATCC 25285)
Bacteroides
fragilis ATCC 25285
ATCC See Supplementary file 1d
Strain, strain
background (Clostridium
sporogenes ATCC 15579)
Clostridium sporogenes
ATCC 15579
ATCC See Supplementary file 1d
Strain, strain
background (Enterococcus
faecalis OG1RF)
Enterococcus
faecalis OG1RF
ATCC See Supplementary file 1d
Strain, strain
background (Edwarsiella
tarda ATCC 23685)
Edwarsiella tarda
ATCC 23685
ATCC See Supplementary file 1d
Sequence-
based reagent
qPCR primers dadh REF 9 PCR primers GAGATCTGGTCCACCGTCAT
and AGTGGAAGTACACCGGGATG
Sequence-
based reagent
qPCR primers E. lenta REF 10 PCR primers CAGCAGGGAAGAAATTCGAC
and TTGAGCCCTCGGATTAGAGA
Sequence-
based reagent
qPCR primers dodh This work PCR primers GFP version of pLKO.1-Puro
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Sequence-
based reagent
Primers for full
length dadh
REF 9 PCR primers ATGGGTAACCTGACCATG
and TTACTCCCTCCCTTCGTA
Sequence-
based reagent
Sequencing primers
SNP506 in dadh
REF 9 PCR primers GGGGTGTCCATGTTGCCGGT
and ACCGGCTACGGCAACGGC
Commercial
assay or kit
DNeasy UltraClean
Microbial Kit
Qiagen, catalog Cat # 12224–50 Extraction of gDNA
from bacterial cultures
Chemical
compound, drug
Dopamine hydrochloride Sigma-Aldrich Cat# PHR1090-1G
Chemical
compound, drug
(+)-catechin hydrate Millipore Sigma Cat# C1251-5G
Chemical
compound, drug
3,4-dihydroxyphenylacetic
acid (DOPAC)
Millipore Sigma Cat# 850217–1G
Chemical
compound, drug
3,4-dihydroxyphenylpropionic
acid (Hydrocaffeic acid)
Millipore Sigma Cat# 102601–10G
Other LC-MS/MS Agilent Agilent:6410 Triple
Quad LC/MS
Other Anaerobic chambers Coy Laboratory
products
Chemical
compound, drug
BBL Brain Heart
Infusion (BHI) media
Beckton Dickinson Cat# L007440
Chemical
compound, drug
L-arginine Sigma-Aldrich Cat# A5006-100G
Chemical
compound, drug
benzyl viologen Sigma-Aldrich Cat# 271845–250 mg
Chemical
compound, drug
methyl viologen Sigma-Aldrich Cat# 856177–1 g
Chemical
compound, drug
sodium dithionite Sigma-Aldrich Cat# 157953–5G
Chemical
compound, drug
diquat Sigma-Aldrich Cat# 45422–250 mg
Chemical
compound, drug
3,4-dihydroxyphenylacetic
acid (ring-d3, 2,2-d2, 98%)
Cambridge Isotope
Laboratories
Cat# DLM-2499–0.01
Chemical
compound, drug
dopamine HCl
(1,1,2,2-d4, 97–98%)
Cambridge Isotope
Laboratories
Cat# DLM-2498–0.1
General materials and methods
The following chemicals were used in this study: tetracycline (Sigma Aldrich, catalog# 87128–25G),
p-tyramine (Sigma Aldrich, catalog# T2879-1G), DL-3,4-Dihydroxymandelic acid (Carbo Synth, cata-
log# FD22118), protocatechuic Acid (Millipore Sigma, catalog# 37580–25 G-F), DL norepinephrine
(Millipore Sigma, catalog# A7256-1G), L-norepinephrine (Matrix Scientific, catalog# 037592–500
MG) L-epinephrine (Alfa Aesar, catalog# L04911.06), DL-epinephrine (Sigma Aldrich, catalog#
E4642-5G), 3,4-dihydroxyphenylacetic acid (Millipore Sigma, catalog# 850217–1G), 3,4-dihydroxyhy-
drocinnamic acid (hydrocaffeic acid) (Millipore Sigma, catalog# 102601–10G), caffeic acid (Millipore
Sigma, catalog# C0625-2G), (+)-catechin hydrate (Millimore Sigma, catalog# C1251-5G), (+/–)-cate-
chin hydrate (Millipore Sigma, catalog# C1788-500MG), (–)-Epicatechin (Millipore Sigma, catalog#
E1753-1G), L-(-)-a-Methyldopa (Chemcruz, catalog# sc-203092), 2,3-dihydroxybenzoic acid (Millipore
Sigma, catalog# 126209–5G), R-(–)-apomorphine hydrochloride hemihydrate (Sigma Aldrich, cata-
log# A4393-100MG), hydroxytyrosol (Ava Chem Scientific, catalog# 2528), enterobactin (generous
gift from Prof. Elizabeth Nolan, MIT), fenoldopam mesylate (Sigma Aldrich, catalog# SML0198-
10MG), 5-hydroxydopamine (Sigma Aldrich, catalog# 151564–100G), 6-hydroxydopamine (Sigma
Aldrich, catalog #H4381-100MG), 3-methoxytyramine (Sigma Aldrich, catalog# M4251-100MG), 3,4-
dihydroxybenzylamine (Sigma Aldrich, catalog# 858781–250 MG), N-methyldopamine (Santa Cruz
Biotechnology, catalog# sc-358430A), 4-(2-aminoethyl)benzene-1,3-diol (Enamine, catalog # EN300-
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65185), m-tyramine (Chemcruz, catalog# sc-255257), 3-hydroxyphenylacetic acid (Sigma Aldrich, cat-
alog# H49901-5G), 3-hydroxyphenylpropionic acid (Toronto Research Chemicals, catalog#
H940090), L-dopa (Oakwood Chemical, catalog# 358380–25 g), dopamine (Sigma-Aldrich, catalog#
PHR1090-1G, or Millipore Sigma, catalog# H8502-25G), m-tyramine (Santa Cruz Biotechnology, cat-
alog# sc-255257), carbidopa (Sigma-Aldrich, catalog# PHR1655-1G), L-arginine (Sigma-Aldrich, cata-
log# A5006-100G), sodium molybdate (Sigma-Aldrich, catalog # 243655–100G), sodium tungstate
(72069–25G), SIGMAFAST protease inhibitor tablets (Sigma-Aldrich, catalog#: S8830), benzyl violo-
gen (Sigma-Aldrich, catalog# 271845–250 mg), methyl viologen (Sigma-Aldrich, catalog# 856177–1
g), diquat (Sigma-Aldrich, catalog# 45422–250 mg), sodium dithionite (Sigma-Aldrich, catalog#
157953–5G), 3,4-dihydroxyphenylacetic acid (ring-d3, 2,2-d2, 98%) (Cambridge Isotope Laborato-
ries, catalog #DLM-2499–0.01), dopamine HCl (1,1,2,2-d4, 97–98%) (Cambridge Isotope Laborato-
ries, catalog #DLM-2498–0.1). LC-MS grade acetonitrile and methanol for LC-MS analyses were
purchased from Honeywell Burdick and Jackson or Sigma-Aldrich. Brain Heart Infusion (BHI) broth
was purchased from Beckton Dickinson (catalog# 211060) or from VWR (catalog# 95021–488).
All bacterial culturing work was performed in an anaerobic chamber (Coy Laboratory Products)
under an atmosphere of 10% hydrogen, 10% carbon dioxide, and nitrogen as the balance, unless
otherwise noted. Hungate tubes were used for anaerobic culturing unless otherwise noted (Chem-
glass, catalog# CLS-4209–01). All lysate work and biochemical experiments were performed in an
anaerobic chamber (Coy Laboratory Products) situated in a cold room at 4˚C under an atmosphere
of 10% hydrogen and nitrogen as the balance. Gut Actinobacterial strains were grown on BHI con-
taining 1% arginine (w/v) to obtain isolated colonies for culturing.
All genomic DNA (gDNA) was extracted from bacterial cultures using the DNeasy UltraClean
Microbial Kit (Qiagen, catalog # 12224–50) according to the manufacturer’s protocol.
LC-MS methods
Method A: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Dikma Technologies Inspire Phenyl column (4.6  150 mm, 5 mm; catalog #81801). The flow rate was
0.5 mL min 1 using 0.1% formic acid in water as mobile phase A and 0.1% formic acid in acetonitrile
as mobile phase B. The column temperature was maintained at room temperature. The following
gradient was applied: 0–2 min: 0% B isocratic, 2–9 min: 0–10% B, 9–11 min: 10–95% B, 11–15 min:
95% B isocratic, 15–18 min: 95–0% B, 18–21 min: 0% B isocratic. For mass spectrometry, the source
temperature was 300˚C, and the masses of dopamine (precursor ion m/z = 154.3, daughter ion m/
z = 137.3), and tyramine (precursor ion m/z = 138.3, daughter ion m/z = 121.3) were monitored at a
collision energy of 15 mV and fragmentor setting of 135 in positive MRM mode.
Method B: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of trihydroxydopamine (precursor ion m/z = 170.3, daughter ion m/z = 153.3), dopa-
mine (precursor ion m/z = 154.3, daughter ion m/z = 137.3), phenylethylamine (precursor ion m/
z = 122.3, daughter ion m/z = 105.2), and tyramine (precursor ion m/z = 138.3, daughter ion m/
z = 121.3) were monitored at a collision energy of 15 mV and fragmentor setting of 135 in positive
MRM mode.
Method C: Samples were analyzed using an Agilent technologies 6530 Accurate-Mass Q-TOF LC/
MS and a Dikma Technologies Inspire Phenyl column (4.6  150 mm, 5 mm; catalog #81801). The
flow rate was 0.4 mL min 1 using 0.1% formic acid in water as mobile phase A and 0.1% formic acid
in acetonitrile as mobile phase B. The column temperature was maintained at room temperature.
The following gradient was applied: 0–2 min: 5% B isocratic, 2–25 min: 0–95% B, 25–30 min: 95% B
isocratic, 30–40 min: 95–5% B. For the MS detection, the ESI mass spectra data were recorded in
positive mode for a mass range of m/z 50 to 3000. A mass window of ±0.005 Da was used to extract
the ion of [M+H].
Method D: Samples were analyzed using an Agilent technologies 6530 Accurate-Mass Q-TOF LC/
MS and a Dikma Technologies Inspire Phenyl column (4.6  150 mm, 5 mm; catalog #81801). The
flow rate was 0.4 mL min 1 using 0.1% formic acid in water as mobile phase A and 0.1% formic acid
in acetonitrile as mobile phase B. The column temperature was maintained at room temperature.
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The following gradient was applied: 0–2 min: 5% B isocratic, 2–25 min: 0–95% B, 25–30 min: 95% B
isocratic, 30–40 min: 95–5% B. For the MS detection, the ESI mass spectra data were recorded in
negative mode for a mass range of m/z 50 to 3000. A mass window of ±0.005 Da was used to
extract the ion of [M+H].
Method E: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of catechin (precursor ion m/z = 289.2, daughter ion m/z = 109.1), benzyl ether
reduced catechin (precursor ion m/z = 291.2, daughter ion m/z = 123.1), benzyl ether reduced,
dehydroxylated catechin (precursor ion m/z = 275.2, daughter ion m/z = 107.1) were monitored at a
collision energy of 15 mV and fragmentor setting of 135 in negative MRM mode.
Method F: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of hydrocaffeic acid (precursor ion m/z = 181.2, daughter ion m/z = 137.2), hydroxy-
phenylpropionic acid (precursor ion m/z = 165.1, daughter ion m/z = 121.2), DOPAC (precursor ion
m/z = 167.2, daughter ion m/z = 123.2), and hydroxyphenylacetic acid (precursor ion m/z = 151.3,
daughter ion m/z = 107.3) were monitored at a collision energy of 15 mV and fragmentor setting of
135 in negative MRM mode.
Method G: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim polar advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 275˚C,
and the masses of norepinephrine (precursor ion m/z = 170.1, daughter ion m/z = 152.1) and octop-
amine (precursor ion m/z = 154.2, daughter ion m/z = 136.1) were monitored at a collision energy of
5 mV and fragmentor setting of 135 in positive MRM mode.
Method H: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 275˚C,
and the masses of caffeic acid (precursor ion m/z = 179.2, daughter ion m/z = 135.2) and coumaric
acid (precursor ion m/z = 163.3, daughter ion m/z = 119.2) were monitored at a collision energy of 5
mV and fragmentor setting of 135 in negative MRM mode.
Method I: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of dihydroxybenzoic acid (precursor ion m/z = 153.1, daughter ion m/z = 137.1) and
hydroxybenzoic acid (precursor ion m/z = 137.1, daughter ion m/z = 93.2) were monitored at a colli-
sion energy of 15 mV and fragmentor setting of 135 in negative MRM mode.
Method J: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of norepinephrine (precursor ion m/z = 184.1, daughter ion m/z = 166.1) and dehy-
droxynorepinephrine (precursor ion m/z = 168.1, daughter ion m/z = 150.1) were monitored at a col-
lision energy of 15 mV and fragmentor setting of 135 in positive MRM mode.
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Method K: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of dihydroxybenzylamine (precursor ion m/z = 140.3, daughter ion m/z = 123.2) and
hydroxybenzylamine (precursor ion m/z = 124.3, daughter ion m/z = 107.2) were monitored at a col-
lision energy of 15 mV and fragmentor setting of 135 in positive MRM mode.
Method L: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of 3-aminotyramine (precursor ion m/z = 153.3, daughter ion m/z = 136.2) and 3-
aminophenylethylamine (precursor ion m/z = 137.3, daughter ion m/z = 120.2) were monitored at a
collision energy of 15 mV and fragmentor setting of 135 in positive MRM mode.
Method M: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses 3-methoxytyramine (precursor ion m/z = 151.1, daughter ion m/z = 91.1) and 3-
methoxyphenylethylamine (precursor ion m/z = 135.1, daughter ion m/z = 75.1) were monitored at a
collision energy of 15 mV and fragmentor setting of 135 in positive MRM mode.
Method N: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses 3-hydroxytyrosol (precursor ion m/z = 153.2, daughter ion m/z = 123.1) and tyrosol
(precursor ion m/z = 137.2, daughter ion m/z = 107.1) were monitored at a collision energy of 15
mV and fragmentor setting of 135 in negative MRM mode.
Method O: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.15 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol
as mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%,
7–9 min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was
300˚C, and the masses of d5-DOPAC (precursor ion m/z = 172.2, daughter ion m/z = 128.2) and d5-
hydroxyphenylacetic acid (precursor ion m/z = 156.3, daughter ion m/z = 113.3) were monitored at
a collision energy of 15 mV and fragmentor setting of 135 in negative MRM mode.
Method P: Samples were analyzed using an Agilent technologies 6410 Triple Quad LC/MS and a
Thermo Scientific Acclaim Polar Advantage II column (3 mM, 120A, 2.1*150 mm, product #: 063187).
The flow rate was 0.2 mL min 1 using 0.1% formic acid in water as mobile phase A and methanol as
mobile phase B. The following gradient was applied: 0–4 min: 50% B isocratic, 4–7 min: 50–99%, 7–9
min: 99–50%, 9–13 min: 50% B isocratic. For mass spectrometry, the source temperature was 300˚C,
and the masses of d4-dopamine (precursor ion m/z = 158.3, daughter ion m/z = 141.3), and d4-tyra-
mine (precursor ion m/z = 142.3, daughter ion m/z = 125.3) were monitored at a collision energy of
15 mV and fragmentor setting of 135 in positive MRM mode.
Colorimetric assay for catechol detection
The colorimetric assay for dopamine dehydroxylation was based on the Arnow test (Arnow, 1937).
Briefly, 50 mL of 0.5 M aqueous HCl was added to 50 mL of culture supernatant. After mixing, 50 mL
of an aqueous solution containing both sodium molybdate and sodium nitrite (0.1 g/mL each) was
added, which produced a yellow color. Finally, 50 mL of 1 M aqueous NaOH was added followed by
pipetting up and down to mix. This allowed the characteristic pink color to develop. Absorbance
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was measured at 500 nm immediately using a Synergy HTX Multi-Mode Microplate Reader (BioTek)
or SPECTROstar Nano (BMG LABTECH).
Anaerobic activity-based purification of E. lenta A2 dopamine
dehydroxylase
Protein purification
Experiments were performed as described previously (Maini Rekdal et al., 2019), with minor modifi-
cations. All procedures were carried out under strictly anaerobic conditions at 4˚C. Procedures out-
side the anaerobic chamber were performed in tightly sealed containers to prevent oxygen
contamination. First, E. lenta A2 starter cultures were inoculated from single colonies into liquid BHI
medium and were grown for 30 hr. Starter cultures were diluted 1:100 into 5 L of BHI medium con-
taining 1% arginine and 10 mM formate and grown anaerobically at 37˚C for 16 hr. Dopamine was
added as a solid to a final concentration of 0.5 mM in the cultures. Cells were pelleted in 5 separate
1 L bottles by centrifugation (6000 rpm, 15 mins), and each pellet was resuspended in 20 mL of 20
mM Tris pH 8 containing 4 mg/mL SIGMAFAST protease inhibitor cocktail. Resuspended cells were
then lysed using two rounds of sonication in an anaerobic chamber (Branson Sonifier 450, 2 min
total, 10 s on, 40 s off, 25% amplitude). The lysates were then clarified by centrifugation (10800 rpm,
15 mins), and the soluble fractions were subjected to two rounds of ammonium sulfate precipitation.
During the precipitation, three different tubes each containing 40 mL total clarified lysate were pre-
cipitated in parallel. Solid ammonium sulfate was first dissolved in these clarified lysates to a final
concentration of 30% (w/v), and lysates were left for 1 hr and 20 min followed by centrifugation to
pellet the precipitates (4000 rpm, 15 mins). The supernatant was saved, and the pellet was dis-
carded. The supernatant was mixed with additional solid ammonium sulfate to achieve a final con-
centration of 40% (w/v) and left for 1 hr and 20 min. Following centrifugation (4000 rpm, 15 mins)
and removal of supernatant, each pellet containing the precipitated proteins was re-dissolved in 20
mL 20 mM Tris pH 8 containing 0.5 M ammonium sulfate. The re-dissolved pellets were combined
and centrifuged to remove particulates (10800 rpm, 15 mins). The resulting 60 mL solution was
injected onto an FPLC (Bio-Rad BioLogic DuoFlow System equipped with GE Life Sciences Dyna-
Loop90) for hydrophobic interaction chromatography (HIC) using 5  1 mL HiTrap Phenyl HP col-
umns (GE Life Sciences, catalog# 17135101). Fractions were eluted with a gradient of 0.5 M to 0 M
ammonium sulfate (in 20 mM Tris pH 8) at a flow rate of 1 mL/min and were tested for activity using
the assay described below. The majority of the dopamine dehydroxylase activity eluted around 0.05
M-0.1 M ammonium sulfate. Active fractions displaying >50% conversion of dopamine were com-
bined and injected onto the FPLC system described above for anion exchange chromatography
using a UNO Q1 column (Bio-Rad, catalog# 720–0001) at a flow-rate of 1 mL/min. Fractions were
eluted using a gradient of 0 to 1 M NaCl in 20 mM Tris pH eight and were tested for activity. The
majority of the dopamine dehydroxylase activity eluted around 250 mM NaCl. Active fractions were
combined and concentrated 20-fold using a spin concentrator with a 5 kDa cutoff (4000 rpm centri-
fugation speed). 250 mL of the concentrate was injected onto FPLC for size exclusion chromatogra-
phy using an Enrich 24 mL column (Enrich SEC 650, 10*300 column, Bio-Rad, catalog# 780–1650).
Fractions were eluted over a 26 mL volume run isocratically in 20 mM Tris pH 8 containing 250 mM
NaCl and were subjected to activity assays. Active fractions were then combined and used for
enzyme assays and were run on SDS-PAGE to assess the presence of protein. Absorbance at 280 nm
was used to determine the protein concentration, using a predicted extinction coefficient of 317735
M 1 cm 1 for the dopamine dehydroxylase.
Activity assays during protein purification
50 mL aliquots of fractions from FPLC runs were mixed, in the following order, with 1 mL electron
donors (final concentration 1 mM each of methyl viologen, 1 mM diquat dibromide, 1 mM benzyl
viologen, all dissolved in water), 2 mL sodium dithionite (2 mM final concentration, dissolved in
water), and 1 mL substrate (500 mM final concentration, dissolved in water). The assay mixtures were
left at room temperature in an anaerobic chamber for 12–14 hr to allow dopamine dehydroxylation
to proceed, followed by assessment of activity using the colorimetric assay for catechol detection.
Due to the inability of Dadh to survive freeze-thawing even in the presence of glycerol, the natively
purified enzyme was always immediately used for enzyme assays.
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Assays of the E. lenta A2 dopamine dehydroxylase substrate scope
Active fractions from the size exclusion chromatography described above were combined and then
diluted in 20 mM Tris pH 8 containing 250 mM NaCl to a final enzyme concentration of 0.1 mM. The
enzyme mixture was transferred the wells of a 96 well plate, for a final volume of 50 mL in each well
(VWR, catalog# 82006–636). 1 mL of substrate (in water, or 50:50 water:DMF for caffeic acid and cat-
echin substrates) was then added at a final concentration of 500 mM. Following this, 1 mL of a solu-
tion containing electron donors (final concentration 1 mM each of methyl viologen, 1 mM diquat
dibromide, 1 mM benzyl viologen, all dissolved in water) and 2 mL of sodium dithionite (2 mM final
concentration, dissolved in water) were added. The resulting solution was mixed by pipetting and
the 96-well plate was then sealed tightly with an aluminum seal. The enzyme assay mixtures were
left at room temperature in an anaerobic chamber for 22 hr to allow dehydroxylation to proceed.
The enzyme reaction mixtures were quenched by bringing the samples out of the anaerobic cham-
ber and freezing at –20˚C. These mixtures were then diluted 1:10 with LC-MS grade methanol and
analyzed by LC-MS/MS. For the screen with physiologically relevant catechol substrates, samples
containing caffeic acid were analyzed using Method H, hydrocaffeic acid and DOPAC were analyzed
using Method F, catechin was analyzed using Method E, protocathecuic acid was analyzed using
Method I, epinephrine was analyzed using Method J, norepinephrine was analyzed using Method G,
and ellagic acid was analyzed using Method D. For the screen with dopamine analogs, all monohy-
droxylated, dihydroxylated, and trihydroxylated phenylethylamine analogs were analyzed using
method B, N-methyldopamine was analyzed using Method C, methoxytyramine was analyzed using
Method M, dihydroxybenzylamine was analyzed using Method K, hydroxytyrosol was analyzed using
Method N, and aminotyramine was analyzed using Method L.
Metabolism of dopamine analogs by E. lenta A2 cells
Cells were cultured in 96-well plates and all experiments were performed anaerobically. The strains
screened for dopamine dehydroxylation have been previously described (Koppel et al., 2018;
Bisanz et al., 2018). E. lenta A2 was inoculated from a single colony into 10 mL of BHI liquid
medium and grown for 48 hr at 37˚C to provide turbid starter cultures. These were diluted 1:10 in
triplicate into 200 mL of fresh BHI medium containing 500 mM substrate (p-tyramine, dopamine, 3,4-
dihydroxybenzylamine, or DL-norepinephrine). These cultures were grown for 48 hr at 37˚C. Cultures
were harvested by centrifugation at 4000 rpm for 10 min, and the supernatants were diluted 1:10
with LC-MS grade methanol. Samples containing dopamine or p-tyramine were analyzed using
Method B, norepinephrine was analyzed using Method G, dihydroxybenzylamine was analyzed using
Method K.
RNA-sequencing experiments with E. lenta A2
We repeated the setup previously used in the RNA-sequencing experiment with dopamine
(Maini Rekdal et al., 2019). Turbid 48 hr starter cultures of E. lenta in BHI medium were inoculated
1:100 into 5 mL of BHI medium containing 1% arginine and 10 mM formate, and cultures were
grown at 37˚C anaerobically. When the cultures reached OD600 = 0.200, hydrocaffeic acid, (+)-cate-
chin, p-tyramine, 3,4-dihydroxybenzylamine, DL-norepinephrine, or N-methyldopamine were added
at final concentrations of 500 mM to triplicate cultures. All compounds except for (+)-catechin were
dissolved in water; (+)-catechin was dissolved in DMF. Control cultures contained vehicle (water or
DMF). Cultures were harvested when they reached OD600 = 0.500. They were centrifuged for 15 min
at 4000 rpm, and cell pellets were re-suspended in 500 mL Trizol reagent (ThermoFisher, catalog#:
15596026). Total RNA was isolated by first bead beating to lyse cells and then using the Zymo
Research Direct-Zol RNA MiniPrep Plus kit (Catalog # R2070) according to the manufacturer’s proto-
col. Illumina cDNA libraries were generated using a modified version of the RNAtag-Seq protocol
(Shishkin et al., 2015). Briefly, 500 ng of total RNA was fragmented, depleted of genomic DNA,
and dephosphorylated prior to its ligation to DNA adapters carrying 5’-AN8-3’ barcodes with a 5’
phosphate and a 3’ blocking group. Barcoded RNAs were pooled and depleted of rRNA using the
RiboZero rRNA depletion kit (Epicentre). These pools of barcoded RNAs were converted to Illumina
cDNA libraries in three main steps: (i) reverse transcription of the RNA using a primer designed to
the constant region of the barcoded adaptor; (ii) addition of a second adapter on the 3’ end of the
cDNA during reverse transcription using SmartScribe RT (Clonetech) as described (Shishkin et al.,
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2015); (iii) PCR amplification using primers that target the constant regions of the 3’ and 5’ ligated
adaptors and contain the full sequence of the Illumina sequencing adaptors. cDNA libraries were
sequenced on Illumina HiSeq 2500. For the analysis of RNAtag-Seq data, reads from each sample in
the pool were identified based on their associated barcode using custom scripts, and up to one mis-
match in the barcode was allowed with the caveat that it did not enable assignment to more than
one barcode. Barcode sequences were removed from the first read as were terminal G’s from the
second read that may have been added by SMARTScribe during template switching. Reads were
aligned to the Eggerthella lenta A2 genome using BWA (Li and Durbin, 2009) and read counts were
assigned to genes and other genomic features using custom scripts. Differential expression analysis
was conducted with DESeq2 (Love et al., 2014) and/or edgeR (Robinson et al., 2010).
RNA-sequencing experiments with G. pamelaeae 3C
Method 1 (compound added at mid-exponential phase): Turbid 48 hr starter cultures of G. pame-
laeae 3C grown in BHI medium were inoculated 1:100 into triplicate Hungate tubes containing 20
mL BHI medium with 10 mM formate. When cultures reached OD600 = 0.110, DOPAC (0.5 mM final)
or vehicle (water) was added to the cultures. The cultures were then grown at 37˚C anaerobically and
harvested when they reached OD600 = 0.185. They were centrifuged, and cell pellets were re-sus-
pended in 500 mL Trizol reagent (ThermoFisher, catalog#: 15596026).
Method 2 (compound added at the beginning of growth): Turbid 48 hr starter cultures of G.
pamelaeae 3C grown in BHI medium were inoculated 1:100 into triplicate hungate tubes containing
20 mL BHI with 10 mM formate and DOPAC (0.5 mM final) or vehicle (water). These cultures were
then left to grow at 37˚C anaerobically. When cultures reached OD600 = 0.110, they were harvested.
They were centrifuged, and cell pellets were re-suspended in 500 mL Trizol reagent (ThermoFisher,
catalog#: 15596026).
RNA extraction and sequencing: this was performed using the exactly same setup as described
above, except the reads were aligned to the genome of Gordonibacter pamelaeae 3C.
Growth of E. lenta A2 in BHI with and without dopamine
Cells were cultured in Hungate tubes and all experiments were performed anaerobically. E. lenta A2
was inoculated from a single colony into 10 mL BHI liquid medium and grown for 48 hr at 37˚C to
provide turbid starter cultures. These were diluted 1:100 in triplicate into 5 mL BHI medium contain-
ing either 0.5 mM dopamine or vehicle. Growth was assessed by measuring the optical density at
600 nm using a Genesys 20 spectrophotometer (Thermo Scientific).
Preparation of basal medium lacking electron acceptors
The medium was prepared as described previously, with minor modifications (Maini Rekdal et al.,
2019). A 100-fold stock solution of salts was first prepared by dissolving 100 g NaCl, 50 g
MgCl2.6H2O, 20 g KH2PO4, 30 g NH4Cl, 30 g KCl, 1.5 g CaCl2  2H2O in 1 L of water. Then, 10 mL
of this solution was added to 1 L of water containing 1 g yeast extract (Beckton Dickinson #288260),
1 g tryptone (Beckton Dickinson #21175), and 0.25 mL of 0.1% resazurin (dissolved in MilliQ water).
This medium was autoclaved. Following autoclaving, the medium was left to cool for 15 min in an
atmosphere of air (outside the anaerobic chamber). After cooling, the following components were
added using sterile technique: 10 mL of ATCC Trace element mix (ATCC, catalog# MD-TMS), 10 mL
of Vitamin Supplement (ATCC, catalog# MD-VS), solid NaHCO3 (SIGMA, 2.52 g, to give 30 mM) and
solid L-cysteine HCl (SIGMA, 63 mg, to give 0.4 mM). The medium had a final pH of 7.2–7.3. The
medium was then sparged with nitrogen gas (for how long) and was brought into the anaerobic
chamber to equilibrate for at least 30 hr prior to use. In all experiments utilizing the basal medium,
except for those experiments performed with Gordonibacter pamelaeae 3C or the screen for cate-
chol metabolism by mammalian gut microbiota samples, sodium acetate was added at a final con-
centration of 10 mM at the time of bacterial inoculation. In experiments performed with
Gordonibacter pamelaeae 3C, sodium formate was added at a final concentration of 10 mM. In the
ex vivo experiments with the mammalian gut microbiota, neither acetate nor formate were added to
the basal medium.
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Growth of single E. lenta strains in basal medium
Cells were cultured in hungate tubes and all experiments were performed anaerobically. E. lenta
strains were inoculated from single colonies into 10 mL of BHI liquid medium and grown for 48–72
hr at 37˚C to provide turbid starter cultures. These were diluted 1:100 in triplicate into 5 mL of basal
medium containing 10 mM acetate and either 1 mM dopamine (in water) or vehicle (water). If appli-
cable. molybdate (0.5 mM), tungstate (0.5 mM), DMSO (14 mM), or nitrate (1 mM) were added at
the time of inoculation. Cultures were grown anaerobically for 36–72 hr at 37˚C. Endpoint growth
was assessed by measuring the optical density at 600 nm using a Genesys 20 spectrophotometer
(Thermo Scientific). Catechol dehydroxylation was assessed at the end of growth in culture superna-
tants using the colorimetric method.
Competition of E. lenta strains in basal medium
Cells were cultured in hungate tubes and all experiments were performed anaerobically. E. lenta
strains W1BHI6 (Tet resistant non-metabolizer, and Valencia (Tet sensitive metabolizer) were inocu-
lated from single colonies into individual tubes containing 10 mL of BHI liquid medium and grown
for 48 hr at 37˚C to provide turbid starter cultures. For the competition experiment, 50 mL of each
starter culture of the two competing strains was combined in triplicate in 5 mL of basal medium con-
taining 10 mM acetate and either 1 mM dopamine or vehicle (water). Following inoculation, cultures
were grown anaerobically for 72 hr at 37˚C. At the end of the incubation, growth of E. lenta was
assessed. Cultures were serially diluted in PBS under anaerobic conditions, and 8 mL of each serial
dilution (10 1 through 10 7) was plated onto BHI plates containing 1% arginine (w/v) with and with-
out 10 mg/mL Tetracycline using a spot plating method. Plates were grown at 37˚C for 72 hr follow-
ing by counting of colonies. To calculate the proportion of metabolizer in the W1BHI6/Valencia
competition experiment, we selected a dilution where distinct colonies were clearly visible (10 4-
10 5) and counted the number of colonies growing on the BHI 1% arginine Tetracycline plates
(W1BHI6) as well as the colonies growing on the BHI 1% arginine plates (Both Valencia and
W1BHI6). To get the number of metabolizer (Valencia) colonies, we subtracted the number of Tet-
raycline resistant colonies from the colonies on the no Tetracycline plate.
Growth of E. lenta strains in the presence of a defined community
Cells were cultured in hungate tubes and all experiments were performed anaerobically. E. lenta
strains, as well as Enterococcus faecalis OGR1F, Escherichia coli MG1655, Bacteroides fragilis ATCC
25285, Clostridium sporogenes ATCC 15579, Edwarsiella tarda ATCC 23685, were inoculated from
single colonies into individual tubes containing 10 mL of BHI liquid medium and grown for 48–72 hr
at 37˚C to provide turbid starter cultures. Growth was assessed by measuring the optical density at
600 nm using a Genesys 20 spectrophotometer (Thermo Scientifc). These starter cultures were then
diluted to a final OD600 of 0.100 in BHI medium anaerobically. The defined community was created
by combining equal volumes of all strains (after diluting each culture to OD600 = 0.100) except for E.
lenta. The community was then inoculated 1:100 in triplicate into 5 mL basal medium containing 10
mM acetate and either 1 mM dopamine or vehicle. E. lenta strains were then added by diluting the
E. lenta starter cultures (normalized to OD600 = 0.100) 1:50 into the tubes containing the defined
community. Cultures were then grown anaerobically for 72 hr at 37˚C. At the end of the incubation,
growth of E. lenta was assessed. Cultures were serially diluted in PBS under anaerobic conditions,
and 8 mL of each serial dilution (10 1 through 10 7) was plated onto BHI plates containing 1% argi-
nine (w/v) and 10 mg/mL Tetracycline (spot plating method). Plates were grown at 37˚C for 72 hr fol-
lowing by counting of colonies.
Human fecal samples used in this study
The human fecal samples used in this study have been previously described (Maini Rekdal et al.,
2019). To prepare them for culturing, all samples were resuspended anaerobically in anaerobic PBS
at a final concentration of 0.1 g/mL. The mixture was vortexed to produce a homogenous slurry and
was then left for 30 min to let particulates settle. Aliquots of the supernatant were dissolved 50:50
with 40% glycerol and flash-frozen in liquid nitrogen, creating slurries that were used for anaerobic
culturing of human fecal samples. Slurries were stored at –80˚C and were thawed anaerobically at
room temperature at the time of use.
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Growth of human fecal samples in basal medium with dopamine
Culturing
Fecal slurries from n = 24 unrelated humans were diluted 1:100 into two different hungate tubes
containing 5 mL of basal medium with 10 mM acetate and either 1 mM dopamine or vehicle (water).
These fecal microbiota cultures were grown anaerobically for 72 hr at 37˚C. Metabolism was then
assessed in culture supernatants using the colorimetric method. In addition, cultures were spun
down and the total community gDNA was extracted from the entire 5 mL of culture for downstream
PCR and qPCR assays as detailed below. qPCR assays for E. lenta and dadh abundance in human
fecal samples grown in basal medium with and without dopamine.
qPCR assays
Assays were performed as previously described (Maini Rekdal et al., 2019). gDNA was extracted
from the culture pellets generated in the experiments described above (‘Growth of fecal samples in
basal medium with dopamine’) using the DNeasy UltraClean Microbial Kit. The extracted DNA from
each culture was used for qPCR assays containing 10 mL of iTaq Universal SYBRgreen Supermix (Bio-
rad, catalog 3: 1725121), 7 mL of water, and 10 mM each of forward and reverse primers. PCR was
performed on a CFX96 Thermocycler (Bio-Rad), using the following program: initial denaturation at
95˚C for 5 min 34 cycles of 95˚C for 1 min, 60˚C for 1 min, 72˚C for 1 min. The program ended with a
final extension at 34˚C for five mins. The primers used were: 16S primers for E. lenta (Haiser et al.,
2013): CAGCAGGGAAGAAATTCGAC and TTGAGCCCTCGGATTAGAGA; primers for dopamine
dehydroxylase: GAGATCTGGTCCACCGTCAT and AGTGGAAGTACACCGGGATG (Maini Rekdal
et al., 2019).
Amplification of dadh and sequencing of SNP506
Amplification of full-length dadh and sequencing of the SNP at position 506 from human fecal sam-
ples grown in basal medium with and without dopamine gDNA was extracted from the culture pel-
lets generated in the experiments described above (‘Growth of fecal samples in basal medium with
dopamine’) using the DNeasy UltraClean Microbial Kit. The extracted DNA from each culture was
used for PCR assays containing 10 mL of Phusion High-Fidelity PCR Master mix with HF buffer (NEB,
catalog# M0531L), 7 mL of water, and 10 mM each of forward and reverse primers. The primers used
to amplify the full-length dopamine dehydroxylase from these samples were ATGGGTAACC
TGACCATG and TTACTCCCTCCCTTCGTA. PCR was performed on a C1000 Touch Thermocycler
(Bio-Rad), using the following program: initial denaturation at 98˚C for 30 s, 34 cycles of 98˚C for 10
s, 61˚C for 15 s, 72˚C for 2.5 mins. The program ended with a final extension at 72˚C for five mins.
Amplicons were purified using the Illustra GFX PCR DNA and Gel Band Purification Kit (GE Health-
care, catalog# 28-9034-70) and were sequenced using Sanger sequencing (Eton Biosciences) for the
region containing the SNP at position 506 using primers GGGGTGTCCATGTTGCCGGT and
ACCGGCTACGGCAACGGC. Sequence chromatograms were analyzed in Ape Plasmid Editor (ver-
sion 2.0.47), and the single nucleotide polymorphism (SNP) at position 506 was called by visual
inspection compared to results obtained from control cultures of E. lenta strains.
Screen of gut Actinobacteria for metabolism of catechols
This procedure was performed in an anaerobic chamber (Coy Laboratory Products, atmospheric con-
ditions: 20% CO2, 2–2.5% H2, and the balance N2)—equilibrating media and consumables to the
atmosphere prior to use—until centrifugation, which was performed using a benchtop centrifuge.
The 96-well plates used in this experiment were purchased from VWR (catalog# 10861–562). Into the
wells of flat-bottom 96-well plates, 100 mL of BHI medium supplemented with L-cysteine-HCl (0.05%,
w/v), L-arginine (1%, w/v), and sodium formate (10 mM) (referred to here as BHI++) were aliquoted.
Seed cultures were prepared by inoculating wells, in triplicate, with Actinobacterial strains that were
cultured on BHI++ agar plates. Additional wells served as sterile controls. Plates were sealed with
tape and incubated at 37˚C for 12 to 18 hr to afford dense cultures. Next, 99 mL of BHI++ medium
containing 500 mM of compound were aliquoted into the wells of a 96-well plate. To these wells, 1
mL of dense seed culture (or sterile control) was added. Plates were sealed and incubated at 37˚C for
24 or 48 hr. Plates were then centrifuged at 2000 rpm for 10 min at 4˚C, and the supernatant was
aspirated and transferred to a fresh 96-well plate. An aliquot (35 mL) of supernatant was then
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immediately screened via the catechol colorimetric assay (described above in ‘Colorimetric assay for
catechol detection’). Absorbance was immediately measured at 500 nm using a plate reader (Spec-
trostar Nano, BMG LABTECH). A standard curve (2-fold serial dilutions, 1000–15.6 mM in BHI++) was
simultaneously prepared, developed, and analyzed using the conditions listed above. The catechol
concentrations in bacterial cultures were normalized to the sterile control. To confirm metabolism of
(+)-catechin, DOPAC, and hydrocaffeic acid, the incubations were repeated following the same pro-
cedure with minor modifications. Strains were grown in BHI for 48 hr anaerobically at 37˚C. Cultures
were harvested by centrifugation and were then analyzed by LC-MS. To prepare samples for LC-MS,
20 mL of the culture supernatant was diluted 1:10 with 180 mL of methanol, followed by centrifuga-
tion at 4000 rpm for 10 min to pellet particulates, salts, and proteins. 50 mL of the resulting superna-
tant was then transferred to a 96-well plate and 5 mL of the supernatant was injected onto the
instrument using Method E for catechin and Method F for hydrocaffeic acid and DOPAC. Following
this screen, select strains were re-cultured to confirm absence/presence of metabolism. The follow-
ing stock solutions were used in the screens: dihydroxymandelic acid (50 mM in water), dopamine
(50 mM in water), protocatechuic acid (50 mM in ethanol), L-dopa (50 mM in 0.5 M HCl), norepi-
nephrine (50 mM in 0.5 M HCl), epinephrine (50 mM in 0.5 M HCl), DOPAC (50 mM in 0.5 M HCl),
Hydrocaffeic acid (50 mM in ethanol), caffeic acid (50 mM in ethanol), (+)-catechin (50 mM in etha-
nol), (+/–)-catechin (50 mM in ethanol), (–)-epicatechin (50 mM in DMSO), methyldopa (solid dis-
solved directly into the media at 0.5 mM final concentration), carbidopa (solid dissolved directly into
the media at 0.5 mM final concentration), dihydroxybenzoic acid (50 mM in methanol). Hydroxytyro-
sol (50 mM in water), enterobactin (10 mM in DMSO), apomorphine (50 mM in DMSO).
Confirmation of dehydroxylation of (+)-catechin and hydrocaffeic acid
by E. lenta A2
Cells were cultured in hungate tubes and all experiments were performed anaerobically. E. lenta A2
was inoculated from a single colony into 10 mL BHI liquid medium and grown for 48 hr at 37˚C to
provide turbid starter cultures. These were diluted 1:100 in triplicate into 5 mL of BHI medium con-
taining either 0.5 mM hydrocaffeic acid (in water), 0.5 mM (+)-catechin (in DMF), or vehicle (water or
DMF). After 48 hr of anaerobic growth at 37˚C, cultures were harvested by centrifugation and were
then analyzed by LC-MS. To prepare samples for LC-MS, 20 mL of the culture supernatant was
diluted 1:10 with 180 mL of methanol, followed by centrifugation at 4000 rpm for 10 min to pellet
particulates, salts, and proteins. 50 mL of the resulting supernatant was then transferred to a 96-well
plate and 5 mL of the supernatant was injected onto the instrument using Method E for catechin and
Method F for hydrocaffeic acid.
Confirmation of dehydroxylation of DOPAC by Gordonibacter
pamelaeae 3C
Cells were cultured in hungate tubes and all experiments were performed anaerobically. G. pame-
laeae 3C was inoculated from a single colony into 10 mL of BHI liquid medium and grown for 48 hr
at 37˚C to provide turbid starter cultures. These were diluted 1:100 in triplicate into 5 mL of BHI
medium containing 10 mM formate and 0.5 mM DOPAC or vehicle (water). After 72 hr of anaerobic
growth at 37˚C, the cultures were harvested by centrifugation and were then analyzed by LC-MS. To
prepare samples for LC-MS, 20 mL of the culture supernatant was diluted 1:10 with 180 mL of metha-
nol, followed by centrifugation at 4000 rpm for 10 min to pellet particulates, salts, and proteins. 50
mL of the resulting supernatant was then transferred to the LC-MS 96-well plate and 5 mL of the
supernatant was injected onto the instrument using Method F for DOPAC.
PBS resuspension assays for inducibility and oxygen sensitivity of
catechol dehydroxylases
Assays with E. lenta A2
Cells were cultured in hungate tubes and all experiments were performed anaerobically. E. lenta A2
was inoculated from a single colony into 10 mL of BHI liquid medium and grown for 48 hr at 37˚C to
provide turbid starter cultures. These were diluted 1:100 in triplicate into 10 mL of BHI medium con-
taining 1% arginine and 10 mM formate and either 0.5 mM dopamine (in water), 0.5 mM hydrocaf-
feic acid (in water), 0.5 mM (+)-catechin (in DMF), or vehicle (water or DMF). After 18 hr of anaerobic
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growth at 37˚C, cultures had reached an OD600 of 0.700 and were harvested by centrifugation (4000
rpm, 15 min). The bacterial pellets were resuspended anaerobically in 10 mL of pre-reduced PBS to
wash the cells, followed by an additional round of centrifugation to pellet the washed cells (4000
rpm, 15 min). The cells were then resuspended in 5 mL of pre-reduced PBS. 0.1 mL aliquots of this
resuspension was transferred to Eppendorf tubes containing either vehicle or 0.5 mM catechol sub-
strate. The samples were vortexed briefly and incubated anaerobically at room temperature for 20
hr to allow for metabolism to proceed. To assess the impact of oxygen on the metabolism of cate-
chols, 0.1 mL of the PBS resuspension in an Eppendorf tube was brought outside the anaerobic
chamber, followed by addition of 0.5 mM substrate in the presence of atmospheric oxygen. The
samples were vortexed briefly and were incubated at room temperature for 20 hr. Samples were
then analyzed by LC-MS. To prepare samples for LC-MS, 20 mL of the culture supernatant was
diluted 1:10 with 180 mL of methanol, followed by centrifugation at 4000 rpm for 10 min to pellet
particulates, salts, and proteins. 50 mL of the resulting supernatant was then transferred to the LC-
MS 96-well plate and 5 mL of the supernatant was injected onto the instrument using Method B for
dopamine, Method E for catechin and Method F for hydrocaffeic acid.
Assays with Gordonibacter pamelaeae 3C
Cells were cultured in hungate tubes and all experiments were performed anaerobically. G. pame-
laeae 3C was inoculated from a single colony into 10 mL of BHI liquid medium and grown for 48 hr
at 37˚C to provide turbid starter cultures. These were diluted 1:100 in triplicate into 10 mL of BHI
medium containing 10 mM formate and either 0.5 mM DOPAC or vehicle. After 18 hr of anaerobic
growth at 37˚C, cultures had reached an OD600 of 0.180 and were harvested by centrifugation (4000
rpm, 15 min). The bacterial pellets were resuspended anaerobically in 10 mL of pre-reduced PBS to
wash the cells, followed by an additional round of centrifugation to pellet the washed cells. The cells
were then resuspended in 5 mL of pre-reduced PBS. 0.1 mL aliquots of this resuspension were trans-
ferred to Eppendorf tubes containing either vehicle or 0.5 mM catechol substrate. The samples were
vortexed briefly and incubated anaerobically at room temperature for 20 hr to allow for metabolism
to proceed. To assess the impact of oxygen on DOPAC metabolism, 0.1 mL of the PBS resuspension
in an Eppendorf tube was brought outside the anaerobic chamber, followed by addition of 0.5 mM
substrate in the presence of atmospheric oxygen. The samples were vortexed briefly and were incu-
bated at room temperature for 20 hr. Samples were then analyzed by LC-MS. To prepare samples
for LC-MS, 20 mL of the culture supernatant was diluted 1:10 with 180 mL of methanol, followed by
centrifugation at 4000 rpm for 10 min to pellet particulates, salts, and proteins. 50 mL of the resulting
supernatant was then transferred to the LC-MS 96-well plate and 5 mL of the supernatant was
injected onto the instrument using Method F.
Effect of tungstate on growth and catechol dehydroxylation by E. lenta
A2 and G. pamelaeae 3C
Assays with E. lenta A2
Starter cultures of E. lenta A2 were grown over 48 hr in 10 mL of BHI medium and then inoculated
1:100 into 200 mL of BHI medium containing either 500 mM dopamine (in water), 500 mM (+)-catechin
(in DMF), or 500 mM hydrocaffeic acid (in water), and either sodium tungstate (0.5 mM, in water),
sodium molybdate (0.5 mM, in water), or vehicle (water or DMF). Cultures were grown for 48 hr
anaerobically at 37˚C and were harvested by centrifugation. Supernatants were dissolved 1:10 in LC-
MS grade methanol and analyzed using LC-MS/MS Methods B, E, or F described above. Experi-
ments were performed anaerobically, and cultures were grown in 96-well plates (VWR, catalog#
29442–054).
Assays with Gordonibacter pamelaeae 3C
Starter cultures of G. pamelaeae 3C were grown over 48 hr in 10 mL of BHI medium and then inocu-
lated 1:100 into 200 mL of BHI medium containing 500 mM DOPAC and either sodium tungstate (0.5
mM, in water), sodium molybdate (0.5 mM, in water), or vehicle (water). Cultures were grown for 48
hr anaerobically at 37˚C and were harvested by centrifugation. Supernatants were dissolved 1:10 in
LC-MS grade methanol and analyzed using LC-MS/MS Method F described above. Experiments
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were performed anaerobically, and cultures were grown in 96-well plates (VWR, catalog# 29442–
054).
Lysate assays for transcriptional and biochemical specificity of
dehydroxylases from G. pamelaeae 3C and E. lenta A2
Assays in E. lenta A2
Bacterial cultures were grown in hungate tubes. All bacterial growth and lysate experiments were
performed in an anaerobic chamber. Lysis and sample processing took place in an anaerobic cham-
ber kept at 4˚C. E. lenta A2 was inoculated from a single colony into 10 mL of BHI liquid medium
and grown for 48 hr at 37˚C to provide turbid starter cultures. These were diluted 1:100 in triplicate
into 50 mL of BHI medium containing 1% arginine and 10 mM formate and either 1 mM dopamine,
1 mM hydrocaffeic acid, 1 mM (+)-catechin, or vehicle. After 18 hr of anaerobic growth at 37˚C, cul-
tures had reached OD600 of 0.700 and were harvested by centrifugation. The bacterial pellets were
resuspended anaerobically in 10 mL of cold, pre-reduced PBS to wash the cells, followed by an addi-
tional round of centrifugation to pellet the washed cells. The washed cells from each culture were
then transferred to an Eppendorf tube and resuspended in 1.4 mL of lysis buffer (20 mM Tris pH 8
containing 4 mg/mL SIGMAFAST protease inhibitor cocktail). The cells were lysed using sonication
in an anaerobic chamber. 50 mL of this lysate was transferred in triplicate to a 96 well plate (VWR,
catalog# 82006–636). 1 mL of substrate was then added to each of the replicates at a final concentra-
tion of 0.5 mM. These samples were incubated anaerobically at room temperature for 28 hr to allow
for metabolism to proceed. Samples were then analyzed by LC-MS. To prepare samples for LC-MS,
20 mL of the culture supernatant was diluted 1:10 with 180 mL of methanol, followed by centrifuga-
tion at 4000 rpm for 10 min to pellet particulates, salts, and proteins. 50 mL of the resulting superna-
tant was then transferred to the LC-MS 96-well plate and 5 mL of the supernatant was injected onto
the instrument using method B for dopamine, method E for catechin and method F for hydrocaffeic
acid.
Assays in Gordonibacter pamelaeae 3C
Bacterial cultures were grown in hungate tubes. All bacterial growth and lysate experiments were
performed in an anaerobic chamber. Lysis and sample processing took place in an anaerobic cham-
ber kept at 4˚C. G. pamelaeae 3C was inoculated from a single colony into 10 mL of BHI liquid
medium and grown for 48 hr at 37˚C to provide turbid starter cultures. These were diluted 1:100 in
triplicate into 50 mL of BHI medium containing 10 mM formate and 1 mM DOPAC or vehicle. After
18 hr of anaerobic growth at 37˚C, cultures had reached OD600 of 0.180 and were harvested by cen-
trifugation. The bacterial pellets were resuspended anaerobically in 10 mL of cold, pre-reduced PBS
to wash the cells, followed by an additional round of centrifugation to pellet the washed cells. The
washed cells from each culture were then transferred to an Eppendorf tube and resuspended in 1.4
mL of lysis buffer (20 mM Tris pH 8 containing 4 mg/mL SIGMAFAST protease inhibitor cocktail).
The cells were lysed using sonication in an anaerobic chamber. 50 mL of this lysate was transferred in
triplicate to a 96 well plate (VWR, catalog# 82006–636). 1 mL substrate was then added to each of
the replicates, for a final concentration of 0.5 mM. These samples were left anaerobically at room
temperature for 28 hr to allow for metabolism to proceed. Samples were then analyzed by LC-MS.
To prepare samples for LC-MS, 20 mL of the culture supernatant was diluted 1:10 with 180 mL of
methanol, followed by centrifugation at 4000 rpm for 10 min to pellet particulates, salts, and pro-
teins. 50 mL of the resulting supernatant was then transferred to the LC-MS 96-well plate and 5 mL of
the supernatant was injected onto the instrument using LC-MS/MS Method F described above.
Comparative genomics among human gut Actinobacteria
To characterize the distribution of Cadh, Hcdh, Dodh among our gut Actinobacterial strain library,
we performed a tBLASTn search. We queried the genomes for Cadh, Hcdh, Dodh and used 90%
coverage, 75% amino acid identity, and e-value = 0 as the cutoff for assessing the presence of each
dehydroxylase.
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Anaerobic activity-based purification of E. lenta A2 hydrocaffeic acid
dehydroxylase
Protein purification
All procedures were carried out under strictly anaerobic conditions at 4˚C. Procedures outside the
anaerobic chamber were performed in tightly sealed containers to prevent oxygen contamination.
First, E. lenta A2 starter cultures were inoculated from single colonies into liquid BHI medium and
were grown for 30 hr. Starter cultures were diluted 1:100 into 8 L of BHI medium containing 1% argi-
nine and 10 mM formate and grown anaerobically at 37˚C for 17 hr. Hydrocaffeic acid (1M stock
solution in water) was added to a final concentration of 0.5 mM in the cultures. Cells were pelleted
in 8 separate 1 L bottles by centrifugation (6000 rpm, 15 mins), and each pellet was resuspended in
12 mL of 20 mM Tris pH 8 containing 4 mg/mL SIGMAFAST protease inhibitor cocktail. Resus-
pended cells were then lysed using two rounds of sonication in an anaerobic chamber (Branson Soni-
fier 450, 2 min total, 10 s on, 40 s off, 25% amplitude). The lysates were then clarified by
centrifugation (10800 rpm, 15 mins), and the soluble fractions were subjected to two rounds of
ammonium sulfate precipitation. During the precipitation, two different tubes each containing 40 mL
total clarified lysate were precipitated in parallel. Solid ammonium sulfate was first dissolved in these
clarified lysates to a final concentration of 30% (w/v), and lysates were left for 1 hr and 30 min fol-
lowed by centrifugation to pellet the precipitates (3300 rcf, 15 mins). The supernatant was saved,
and the pellet was discarded. The supernatant was mixed with additional solid ammonium sulfate to
achieve a final concentration of 40% (w/v) and left for 1 hr and 30 min. Following centrifugation
(3300 rcf rpm, 15 mins) and removal of supernatant, each pellet containing the precipitated proteins
was re-dissolved in 20 mL 20 mM Tris pH 8 containing 0.5 M ammonium sulfate. The re-dissolved
pellets were combined and centrifuged to remove particulates (10800 rpm, 15 mins). The resulting
80 mL solution was injected onto an FPLC (Bio-Rad BioLogic DuoFlow System equipped with GE Life
Sciences DynaLoop90) for hydrophobic interaction chromatography (HIC) using 4  1 mL HiTrap
Phenyl HP columns strung together (GE Life Sciences, catalog# 17135101). Fractions were eluted
with a gradient of 0.5 M to 0 M ammonium sulfate (in 20 mM Tris pH 8) at a flow rate of 1 mL/min
and were tested for activity using the assay described below. The majority of the hydrocaffeic acid
dehydroxylase activity eluted around 0.2 M-0.5M ammonium sulfate. Active fractions display-
ing >50% conversion of hydrocaffeic acid were combined and injected onto the FPLC system
described above for anion exchange chromatography using a UNO Q1 column (Bio-Rad, catalog#
720–0001) at a flow-rate of 1 mL/min. Fractions were eluted using a gradient of 0 to 1 M NaCl in 20
mM Tris pH eight and were tested for activity. The majority of the hydrocaffeic acid dehydroxylase
activity eluted around 200–400 mM NaCl. Active fractions were combined and concentrated 20-fold
using a spin concentrator with a 5 kDa cutoff (3300 rcf centrifugation speed). 500 mL of the concen-
trate was injected onto FPLC for size exclusion chromatography using an Enrich 24 mL column
(Enrich SEC 650, 10*300 column, Bio-Rad, catalog# 780–1650). Fractions were eluted over a 26 mL
volume run isocratically in 20 mM Tris pH 8 containing 250 mM NaCl and were subjected to activity
assays. Active fractions were then combined and used for enzyme assays and were run on SDS-
PAGE to assess the presence of protein.
Activity assays during protein purification
100 mL aliquots of fractions from FPLC runs were mixed, in the following order, with 1 mL of methyl
viologen (0.5 mM final concentration), 2 mL sodium dithionite (1 mM final concentration, dissolved in
water), and 1 mL substrate (500 mM final concentration, dissolved in water). The assay mixtures were
left at room temperature in an anaerobic chamber for 12–14 hr to allow dehydroxylation to proceed,
followed by assessment of activity using the colorimetric assay for catechol detection.
Proteomics of E. lenta A2 hydrocaffeic acid dehydroxylase
Sample preparation
The cut-out gel band was washed twice with 50% aqueous acetonitrile for five minuts followed by
drying in a SpeedVac. The gel was then reduced with a volume sufficient to completely cover the gel
pieces (100 mL) of 20 mM TCEP in 25 mM TEAB at 37˚C for 45 min. After cooling to room temp, the
TCEP solution was removed and replaced with the same volume of 10 mM iodoacetamide Ultra
(Sigma) in 25 mM TEAB and kept in the dark at room temperature for 45 min. Gel pieces were
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washed with 200 mL of 100 mM TEAB (10 min). The gel pieces were then shrunk with acetonitrile.
The liquid was then removed followed by swelling with the 100 mM TEAB again and dehydration/
shrinking with the same volume of acetonitrile. All of the liquid was removed, and the gel was
completely dried in a SpeedVac for ~20 min. 0.06 mg/5 mL of trypsinin 50 mM TEAB was added to
the gel pieces and the mixture was placed in a thermomixer at 37˚C for about 15 min. 50 mL of 50
mM TEAB was added to the gel slices. The samples were vortexed, centrifuged, and placed back in
the thermomixer overnight. Samples were digested overnight at 37˚C. Peptides were extracted with
50 mL 20 mM TEAB for 20 min and 1 change of 50 mL 5% formic acid in 50% acetonitrile at room
temp for 20 min while in a sonicator. All extracts obtained were pooled into an HPLC vial and were
dried using a SpeedVac to the desired volume (~50 mL). This sample was used for protein identifica-
tion by LC-MS/MS, as described below.
Mass spectrometry
Each sample was submitted for a single LC-MS/MS experiment that was performed on an LTQ Orbi-
trap Elite (Thermo Fischer) equipped with a Waters (Milford, MA) NanoAcquity HPLC pump. Pepti-
des were separated using a 100 mm inner diameter microcapillary trapping column packed first with
approximately 5 cm of C18 Reprosil resin (5 mm, 100 A˚, Dr. Maisch GmbH, Germany) followed
by ~20 cm of Reprosil resin (1.8 mm, 200 A˚, Dr. Maisch GmbH, Germany). Separation was achieved
through applying a gradient of 5–27% ACN in 0.1% formic acid over 90 min at 200 nL min 1. Elec-
trospray ionization was enabled through applying a voltage of 1.8 kV using a home-made electrode
junction at the end of the microcapillary column and sprayed from fused silica pico tips (New Objec-
tive, MA). The LTQ Orbitrap Elite was operated in data-dependent mode for the mass spectrometry
methods. The mass spectrometry survey scan was performed in the Orbitrap in the range of 395–
1,800 m/z at a resolution of 6  104, followed by the selection of the twenty most intense ions
(TOP20) for CID-MS2 fragmentation in the Ion trap using a precursor isolation width window of 2 m/
z, AGC setting of 10,000, and a maximum ion accumulation of 200 ms. Singly charged ion species
were not subjected to CID fragmentation. Normalized collision energy was set to 35 V and an activa-
tion time of 10 ms. Ions in a 10 ppm m/z window around ions selected for MS2 were excluded from
further selection for fragmentation for 60 s. The same TOP20 ions were subjected to HCD MS2
event in Orbitrap part of the instrument. The fragment ion isolation width was set to 0.7 m/z, AGC
was set to 50,000, the maximum ion time was 200 ms, normalized collision energy was set to 27 V
and an activation time of 1 ms for each HCD MS2 scan.
Mass spectrometry data analysis
Raw data were submitted for analysis in Proteome Discoverer 2.1.0.81 (Thermo Scientific) software.
Assignment of MS/MS spectra were performed using the Sequest HT algorithm by searching the
data against a protein sequence database including a custom database from Eggerthella lenta A2
and other sequences such as human keratins and common lab contaminants. Sequest HT searches
were performed using a 20 ppm precursor ion tolerance and requiring each peptide’s N-/C-termini
to adhere with trypsin protease specificity, while allowing up to two missed cleavages. Cysteine car-
bamidomethyl (+57.021) was set as a static modification while methionine oxidation (+15.99492 Da)
was set as a variable modification. A MS2 spectra assignment false discovery rate (FDR) of 1% on
protein level was achieved by applying the target-decoy database search. Filtering was performed
using a Percolator (64bit version). For quantification, a 0.02 m/z window centered on the theoretical
m/z value of each the six reporter ions and the intensity of the signal closest to the theoretical m/z
value was recorded. Reporter ion intensities were exported in result file of Proteome Discoverer 2.1
search engine as an excel tables.
Assays of partially purified E. lenta A2 hydrocaffeic acid dehydroxylase
substrate scope
Active fractions from the size exclusion chromatography described above were combined and then
diluted 1:5 in 20 mM Tris pH 8 containing 250 mM NaCl. The enzyme mixture was transferred the
wells of a 96 well plate, for a final volume of 50 mL in each well (VWR, catalog# 82006–636). 1 mL of
substrate (in water for hydrocaffeic acid, dopamine, and DOPAC, or 50:50 water:DMF for (+)-cate-
chin) was then added at a final concentration of 500 mM. Following this, 1 mL of a solution containing
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methyl viologen (1 mM final concentration) and 2 mL of sodium dithionite (2 mM final concentration,
dissolved in water) were added. The resulting solution was mixed by pipetting and the 96-well plate
was then sealed tightly with an aluminum seal. The enzyme assay mixtures were left at room temper-
ature in an anaerobic chamber for 26 hr to allow dehydroxylation to proceed. The enzyme reaction
mixtures were quenched by bringing the samples out of the anaerobic chamber and freezing at –20˚
C. These mixtures were then diluted 1:10 with LC-MS grade methanol and analyzed by LC-MS/MS.
Samples containing hydrocaffeic acid and DOPAC were analyzed using Method F, catechin was ana-
lyzed using Method E, and dopamine was analyzed using Method C.
Metagenomic analysis of catechol dehydroxylase abundance and
prevalence across human patients
To generate estimates of the enzyme prevalence in human populations, the amino acid sequences
of Cldh, Dodh, Dadh, Hcdh, and Cadh were searched against a non-redundant gut microbiome
gene catalogue using BLASTP with a minimum 70% percent identity, query coverage and target cov-
erage and used to extract per-sample gene abundances from a collection of human metagenomes
(10.1093/bioinformatics/btv382). High identity matches were obtained for all queries (81.7%, 81.7%,
100%, 99.5%, and 99.9% respectively over >99% target coverage) with a second lower-identity
match observed for Hcdh (75.7%) for which abundances were summed with the higher identity hit.
Next, to account for repeated sampling of individuals, the median gene abundance across a sub-
ject’s samples was calculated and carried forward for prevalence estimates leading to a total of 1872
human subjects considered (Nayfach et al., 2015). Prevalence was then calculated as a rolling func-
tion of minimum abundance.
Incubation of human fecal samples with d4-dopamine, hydrocaffeic acid,
(+)-catechin, and d5-DOPAC
Culturing
20 mL of fecal slurries from n = 12 unrelated humans were diluted 1:50 into three independent cul-
tures containing 980 mL of BHI and 0.5 mM substrate. As positive controls, saturated cultures of 20
mL E. lenta A2 or G. pamelaeae 3C (grown from a glycerol stock for 48 hr in BHI) were added in trip-
licate to 980 mL BHI and 0.5 mM hydrocaffeic acid, (+)-catechin, d4-dopamine for E. lenta A2, and
d5-DOPAC for G. pamelaeae 3C. These cultures were grown anaerobically for 72 hr at 37˚C. The cul-
tures were harvested by centrifugation and 20 mL was then diluted 1:10 with LC-MS grade methanol
and analyzed by LC-MS/MS using Method F for samples grown with hydrocaffeic acid, Method P for
d4-dopamine, Method O for d5-DOPAC, and Method E for catechin. In addition, the total commu-
nity gDNA was extracted from the remaining 980 mL of culture growth with d5-DOPAC for down-
stream qPCR assays as detailed below. The experiment was performed in a 96 well plate (Agilent,
catalog# A696001000).
qPCR assays
gDNA was extracted from the culture pellets generated in the experiments described above (‘Incu-
bation of human fecal samples with d4-dopamine, hydrocaffeic acid, (+)-catechin, and d5-DOPAC’)
using the DNeasy UltraClean Microbial Kit. 40 ng of the extracted DNA (2 mL) from each culture was
used for qPCR assays containing 10 mL of iTaq Universal SYBRgreen Supermix (Bio-rad, catalog 3:
1725121), 7 mL of water, and 10 mM each of forward and reverse primers. PCR was performed on a
CFX96 Thermocycler (Bio-Rad), using the following program: initial denaturation at 95˚C for 5 min 34
cycles of 95˚C for 1 min, 60˚C for 1 min, 72˚C for 1 min. The program ended with a final extension at
34˚C for five mins. The primers used for dodh were TACGCCTACAACAGCTCCAA and ACATCATC
TGGGGCGGATAC. Data analysis was performed in graphpad prism (version 8).
Phylogenetic analysis of relationship between catechol dehydroxylases
and other characterized members of the bis-molybdopterin guanine
dinucleotide enzyme family
For phylogenetic analysis of the bis-MGD enzymes, we gathered sequences that have been previ-
ously used to study the evolution of bis-MGD enzymes (Schoepp-Cothenet et al., 2012). However,
we also added sequences to capture additional diversity of biochemically characterized bis-MGD
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 36 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
enzymes that were not included in the original tree described in Schoepp-Cothenet et al. (2012). In
particular, we performed a pBLAST search in Uniprot using perchlorate reductase (Uniprot ID#
PCRA_DECAR), ethylbenzene dehydrogenase (Uniprot ID# Q5NZV2_AROAE), acetylene hydratase
(Uniprot ID# AHY_PELAE), and pyrogallol transhydroxylase (Uniprot ID# PGTL_PELAC) as the
queries, and collected sequences with 85–90% amino acid ID. In addition, we added the sequences
of Dadh, Hcdh, Cadh from E. lenta A2, and Dodh and Cldh (Bess et al., 2020) from G. pamelaeae
3C. The sequences were combined with those reported in Schoepp-Cothenet et al. (2012) and
were aligned in Geneious (version 11) using MUSCLE. We subsequently used FastTree (standard set-
tings, 20 rate categories of sites) to create a maximum likelihood tree. The tree files were uploaded
to the Interactive Tree of Life web server (https://itol.embl.de/) to annotate the trees (Letunic and
Bork, 2016).
Construction of sequence similarity network of the bis-molybdopterin
guanine dinucleotide enzyme family
A SSN was generated using the EFI-EST tool (http://efi.igb.illinois.edu/efi-est/) on July 15 2017
(Gerlt et al., 2015). In particular, we generated an SSN of the molybdopterin dinucleotide binding
domain enzyme superfamily (PF01568), including sequences between 600 and 1400 amino acids in
length and using an initial alignment score of e-150. Nodes represented sequences with 75% amino
acid identity. The SSN was imported into Cytoscope v 3.2.1 and visualized with the ‘Organic layout’
setting. The alignment score cutoff was increased to e-167 until the groups of biochemically charac-
terized enzymes included in our phylogenetic analysis (Figure 6) separated from each other into
putatively isofunctional clusters.
Phylogenetic analysis of catechol dehydroxylases encoded by gut
Actinobacteria and environmental isolates
To identify additional diversity beyond the newly identified putative dehydroxylases from this study,
we created a database containing putative homologs from a collection of 26 previously sequenced
Actinobacterial genomes (Bisanz et al., 2018), as well as from genomes publicly available through
NCBI. First, the Eggerthella lenta A2 dopamine dehydroxylase (Dadh) protein sequence was used as
the query sequence for a tBLASTn search of 26 previously sequenced Actinobacterial genomes
(Bisanz et al., 2018) (April 23, 2019). The genomes were loaded in Geneious (version 11) and hits
with an amino acid ID of >30% and e-value of e-34 were considered potential dehydroxylase hits
and were saved. This cutoff was chosen because sequences captured within this window more
closely resembled the acetylene hydratase and Dadh than to any other biochemically characterized
moco enzyme, as assessed by percent amino acid identity. In addition, we used the representative
Gordonibacter enzyme Cldh as a separate query to identify the more distantly related, smaller
enzymes from Gordonibacter that were not detected when using the large, multi-subunit Dadh as
the query. Specifically, we used tBLASTn to search the 26 Actinobacterial genomes for the Gordoni-
bacter pamelaeae 3C Cldh protein sequence. Hits from Paraeggerthella hongongensis, Gordoni-
bacter pamelaeae 3C and Gordonibacter sp. 28C, the only organisms containing these smaller Cldh-
like enzymes in our collection, were saved. Again, amino acid ID of >30% and e-value of e-34 were
considered potential hits because sequences captured within this window more closely resembled
the acetylene hydratase and Dadh than to any other biochemically characterized moco enzyme, as
assessed by percent amino acid identity. The hits from our searches with Cldh and Dadh were com-
bined into a preliminary database in Geneious. To expand the sequence diversity within this data-
base, we used Cldh and Dadh as queries for two separate tBLASTn searches in NCBI (nucleotide
collection). To ensure that we captured diversity beyond human gut microbes, we excluded Gordo-
nibacter and Eggerthella as organisms in the tBLASTn searches for Cldh and Dadh queries, respec-
tively. For the two searches, sequences of >29% amino acid ID and e-value of e-55 were considered
potential dehydroxylase hits. This was a more conservative cutoff than we used with human Actino-
bacteria and was selected based on the observation that the pBLAST alignment of Dadh and Cldh
has an e value of e-45% and 29% amino acid ID. The sequences retrieved from NCBI were added to
the database already containing the hits from searches of the 26 Actinobacterial genomes. In addi-
tion, we added the biochemically characterized E. coli bis-MGD enzyme DMSO reductase (DmsA,
Uniprot ID#P18775) to this database as the outgroup. This sequence was also used as the root of
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the tree. For phylogenetic analysis of these sequences, we first aligned sequences in Geneious using
MUSCLE and removed sequences that were 95% identical to each other (considered duplicates).
After deleting these duplicate sequences, we re-aligned the sequences using MUSCLE (standard set-
tings) and subsequently used FastTree (standard settings, 20 rate categories of sites) to create a
maximum likelihood tree. The tree files were uploaded to the Interactive Tree of Life web server
(https://itol.embl.de/) to annotate the trees (Letunic and Bork, 2016).
Phylogenetic analysis of relationship between representative
dehydroxylase homologs (from Figure 7—figure supplement 3 and
Supplementary file 3b) and other characterized members of the bis-
molybdopterin guanine dinucleotide enzyme family
Once we had constructed the two trees described above (Figures 6 and 7 in the main text) and
uncovered dehydroxylase homologs in gut and environmental bacteria, we wanted to explore the
phylogenetic relationship between these enzymes and the broader bis-molybdopterin guanine dinu-
cleotide (bis-MGD) enzyme family. To do this, we added the representative sequences from Fig-
ure 7—figure supplement 3 and Supplementary file 3c to the sequence database already
described in ‘Phylogenetic analysis of relationship between catechol dehydroxylases and other char-
acterized members of the bis-molybdopterin guanine dinucleotide enzyme family’. Using MUSCLE,
we aligned the newly added sequences with the sequences represented on the tree (Figure 6 in
main text). We then used FastTree (standard settings, 20 rate categories of sites) in Geneious (ver-
sion 11) to generate the tree seen in Figure 7—figure supplement 4. The tree files were uploaded
to the Interactive Tree of Life web server (https://itol.embl.de/) to annotate the trees (Letunic and
Bork, 2016).
Mammalian fecal samples used in this study
The collection of fecal samples from mammals (n = 12 different species, n = 3 individuals per spe-
cies) has been previously described (Reese et al., 2018). To prepare these samples for culturing, all
samples were resuspended anaerobically in pre-reduced PBS at a final concentration of 0.1 g/mL.
The mixture was vortexed to produce a homogenous slurry and was then left for 30 min to let partic-
ulates settle. Aliquots of the supernatant were dissolved 50:50 with 40% glycerol in water and flash-
frozen in liquid nitrogen, creating slurries. These slurries were stored at –80˚C and were defrosted
anaerobically at room temperature at the time of use.
Screen for catechol dehydroxylation by mammalian gut microbiota
samples
Mammalian fecal slurries were prepared as described above and were defrosted by incubation at
room temperature at the time of use. 20 mL of each slurry was then combined with 980 mL of basal
medium containing 500 mM each of dopamine, (+) catechin, DOPAC, or hydrocaffeic acid. Each indi-
vidual sample was grown in one well, with the n = 3 individual samples for each animal serving as
the biological replicates. Control wells contained compound but no bacteria. Samples were grown
anaerobically at 37˚C for 96 hr in a 96-well plate (Agilent Technology, catalog# A696001000). Follow-
ing growth, we first assessed the total microbial growth by measuring the OD600 in a plate reader
(BioTek Synergy HTX). Cultures were then harvested by centrifugation and 50 mL of supernatant was
transferred to a new 96-well plate, at which time the catechol colorimetric assay was used to assess
total dehydroxylation by the complex microbial community. Samples that had potential catechol
depletion as assessed by the colorimetric assay were then further analyzed by LC-MS. To prepare
samples for LC-MS, 20 mL of the culture supernatant was diluted 1:10 with 180 mL of methanol, fol-
lowed by centrifugation at 4000 rpm for 10 min to pellet particulates, salts, and proteins. 50 mL of
the resulting supernatant was then transferred to the LC-MS 96-well plate and 5 mL of the superna-
tant was injected onto the instrument using Method A for dopamine, Method E for catechin, and
Method F for DOPAC and hydrocaffeic acid.
Construction of a mammalian phylogenetic tree
The mammalian phylogenetic tree was generated using the Automatic Phylogenetic Tree Generator
(aptg, version 0.1.0) script in R (version 3.5.1). Mammals not part of the aptg database were added
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manually to the tree using additional information about the mammalian phylogeny as a reference
(Reese et al., 2019). The mammalian icons were adapted under a Creative Commons license
(https://creativecommons.org/licenses/by/3.0/) at phylopic (http://phylopic.org), including Alpaca
logo (made by Steven Traver), Bison (Lukasiniho). Cow (Steven Traver), Dog (Tracy A Heath), Fox
(Anthony Caravaggi), Guinea pig (Zimices), Mouse (Madeleine Price Ball), Pig (Steven Traver), Rabbit
(Steven Traver), Rabbit (Steven Traver), Rat (Rebecca Groom), Sheep (Zimices), and Wolf (Tracy A.
Heath).
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exposure of G. pamelaeae 3C to 0.5 mM DOPAC relative to vehicle (>|2|-fold difference, FDR < 0.1)
when catechol was added during the beginning of growth. G. pamelaeae 3C was grown with 500
mM DOPAC or a vehicle control in BHI medium containing 10 mM formate. Cells were harvested in
mid-exponential phase when metabolism appeared. The catalytic subunit of the putative DOPAC
dehydroxylase (dodh), as well as its predicted 4Fe-4S partner, are highlighted in red. Data are from
n = 3 cultures for each condition. The experiment was performed once. Supplementary file 2f. Prote-
omics identification of proteins in the band of interest during the activity-based native purification of
the hydrocaffeic acid dehydroxylase from E. lenta A2. The band highlighted with a red asterisk in
Figure 4—figure supplement 4 was cut out and subjected to proteomics. This band was confirmed
to contain the catalytic subunit of the hydrocaffeic acid dehydroxylase (highlighted in red). The pre-
dicted size of 133.9 kDa (a) is for the full peptide containing the Twin Arginine Translocation (TAT)
signal sequence. The predicted size of 130.5 kDa (b) is for the processed, mature peptide where the
TAT signal sequence has been removed, as is suggested from the coverage map in Figure 4—figure
supplement 5.
. Supplementary file 3. Tables containing accession numbers for protein sequences used in bioinfor-
matics analyses of catechol dehydroxylase enzymes. Supplementary file 3a. Accession numbers (Uni-
prot and Genbank) of putative Eggerthella and Gordonibacter dehydroxylases identified in this
study. Supplementary file 3b. Accession numbers of bis-MGD enzymes used to generate the phylo-
genetic tree of the bis-MGD enzyme family (Figure 6). Supplementary file 3c. Accession numbers
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Appendix 1
Materials, methods, references, and characterization data
for synthesis of dopamine analogs
General materials and methods
All reactions were performed in dried glassware under an atmosphere of dry N2. Reaction
mixtures were stirred magnetically unless otherwise indicated and monitored by thin layer
chromatography (TLC) on Merck precoated glass-backed silica gel 60 F-254 0.25 mm plates
with visualization by fluorescence quenching at 254 nm. TLC plates were stained using a
potassium permanganate solution. Chromatographic purification of products (flash column
chromatography) was performed on Silicycle Silica Flash F60 (230–400 Mesh) silica gel using a
forced flow of eluent at 0.3–0.5 bar. Concentration of reaction product solutions and
chromatography fractions under reduced pressure was performed by rotary evaporation at
35–40˚C at the appropriate pressure and then at rt, ca. 0.1 mmHg (vacuum pump) unless
otherwise indicated.
All chemicals were purchased from Acros, Aldrich, Fluka, Merck, ABCR, TCI, Alfa Aesar or
Strem and used as such unless stated otherwise. Commercial grade reagents and solvents
were used without further purification except as indicated below. Toluene, diethylether (Et2O),
tetrahydrofuran (THF) and dichloromethane (CH2Cl2) were purified by pressure filtration
through activated alumina. N,N-Dimethylformamide (DMF), acetonitrile (CH3CN), and ethanol
(EtOH) were used as purchased. Yields given refer to chromatographically purified and
spectroscopically pure compounds unless otherwise stated.
Infrared (IR) spectra were recorded on a Bruker ALPHA FT-IR spectrophotometer and
reported as wavenumber (cm 1) of the absorption maxima for the range between 4000 cm 1
and 750 cm 1 with only major peaks reported. 1H NMR and 13C NMR spectra were recorded
on a Varian-Inova-500 500 MHz, 125 MHz spectrometer. 1H NMR chemical shifts are
expressed in parts per million (d) downfield from tetramethylsilane (with the CHCl3 peak at
7.26 ppm, MeOH peak at 3.31, DMSO peak at 2.50, and acetone peak at 2.05 used as a
standard). 13C NMR chemical shifts are expressed in parts per million (d) downfield from
tetramethylsilane (with the central peak of CHCl3 at 77.16 ppm, MeOH peak 49.00, DMSO
peak at 39.52, and acetone peak at 29.84 used as a standard). All 13C spectra were measured
with complete proton decoupling. NMR coupling constants (J) are reported in Hertz (Hz), and
splitting patterns are indicated as follows: br, broad; s, singlet; d, doublet; dd, doublet of
doublet; t, triplet; m, multiplet. High-resolution mass spectrometric measurements (HRMS)
were performed on an Accurate-Mass 6530 Q-TOF LC/MS (Agilent) using dual electrospray
ionization (ESI).
Preparation of 2-aminoethylbenzenediol /- triol
derivatives
All reactions were carried out with degassed solvents under a positive pressure of nitrogen
2-PHENYLACETIC ACID DERIVATIVES AS STARTING MATERIALS
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Appendix 1—scheme 1. Preparation of 2-phenylacetic acid derivatives.
Appendix 1—scheme 2. Reduction of benzyl carboxylic acids.
General carboxylicacid reduction procedure
BH3 . SMe2 (2.0 M in THF; 1.30 equiv) was added dropwise to a solution of commercially
available di-/trimethoxyphenylacetic acid (1.00 equiv) in THF (0.25 M) at 0˚C. The resulting
mixture was allowed to warm to rt over 3 hr and stirring was continued for 14 hr while a
colorless solid formed. The obtained suspension was cooled to 0˚C and carefully quenched
with the dropwise addition of saturated aqueous NaHCO3. The layers were separated, and the
aqueous layer was extracted with EtOAc (3  50 mL). The combined organic layers were
washed with H2O (2  20 mL), brine (2  20 mL), dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure to yield analytically pure alcohol S1–S5 that was used in
the next step without further purification.
Appendix 1—chemical structure 1. Dimethoxyphenethyl alcohol (S1).
2-(2,3-Dimethoxyphenyl)ethan-1-ol (S1). Following the general carboxylic acid reduction
procedure using 2-(2,3-dimethoxyphenyl)acetic acid (2.00 g, 10.2 mmol), alcohol S1 was
obtained as a colorless oil (1.85 g, quant.). 1H NMR (500 MHz, CDCl3): d 7.01 (t, J = 7.9 Hz,
1H), 6.88–6.75 (m, 2H), 3.87 (s, 3H), 3.84 (s, 3H), 3.84 (t, J = 6.5 Hz, 2H), 2.91 (t, J = 6.5 Hz,
2H), 1.76 (br s, OH); 13C NMR (125 MHz, CDCl3): d 152.8, 147.4, 132.6, 124.2, 122.6, 111.0,
63.4, 60.7, 55.7, 33.8. The spectral characteristics were identical to those reported in the
current literature, which fails to report the signals for the OMe and one of the CH2 groups
(Macchia et al., 1993).
Appendix 1—chemical structure 2. Dimethoxyphenethyl alcohol (S2).
2-(3,5-Dimethoxyphenyl)ethan-1-ol (S2). Following the general carboxylic acid reduction
procedure using 2-(3,5-dimethoxyphenyl)acetic acid (1.00 g, 5.10 mmol), alcohol S2 was
obtained as a colorless oil (920 mg, quant.). 1H NMR (500 MHz, CDCl3): d 6.39 (d, J = 2.4 Hz,
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2H), 6.36–6.33 (m, 1H), 3.86 (t, J = 6.4 Hz, 2H), 3.79 (s, 6H), 2.82 (t, J = 6.4 Hz, 2H), 1.45 (br s,
OH). The spectral characteristics were identical to those reported in the current literature
(Yoshida et al., 2016).
Appendix 1—chemical structure 3. Dimethoxyphenethyl alcohol (S3).
2-(2,5-Dimethoxyphenyl)ethan-1-ol (S3). Following the general carboxylic acid reduction
procedure using 2-(2,5-dimethoxyphenyl)acetic acid (2.00 g, 10.2 mmol), alcohol S3 was
obtained as a colorless oil (1.70 g, 92% yield). 1H NMR (500 MHz, CDCl3): d 6.80 (d, J = 8.6
Hz, 1H), 6.77–6.71 (m, 2H), 3.83 (t, J = 6.4 Hz, 2H), 3.79 (s, 3H), 3.76 (s, 3H), 2.88 (t, J = 6.4 Hz,
2H), 1.72 (br s, OH). The spectral characteristics were identical to those reported in the current
literature (Gerdes et al., 1996).
Appendix 1—chemical structure 4. Trimethoxyphenethyl alcohol (S4).
2-(2,3,4-Trimethoxyphenyl)ethan-1-ol (S4). Following the general carboxylic acid reduction
procedure using 2-(2,3,4-trimethoxyphenyl)acetic acid (2.00 g, 8.84 mmol), alcohol S4 was
obtained as a colorless oil (1.87 g, quant.). IR (thin film) n 3348, 2926, 2850, 1769, 1658, 1602,
1498, 1395, 1091, 840 cm-1; 1H NMR (500 MHz, CDCl3): d 6.86 (d, J = 8.4 Hz, 1H), 6.63 (d,
J = 8.4 Hz, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 3.84 (s, 3H), 3.80 (t, J = 6.4 Hz, 2H), 2.83 (t, J = 6.4
Hz, 2H), 1.79 (br s, OH); 13C NMR (125 MHz, CDCl3): d 152.6, 152.1, 142.4, 124.7, 124.7,
107.5, 63.5, 61.0, 60.8, 56.1, 33.6; ESI-HRMS calcd for C11H17O4 [M+H] 213.1121, found
213.1128.
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Appendix 1—chemical structure 5. Trimethoxyphenethyl alcohol (S5).
2-(2,4,6-Trimethoxyphenyl)ethan-1-ol (S5). Following the general carboxylic acid reduction
procedure using 2-(2,4,6-trimethoxyphenyl)acetic acid (1.00 g, 4.42 mmol), alcohol S5 was
obtained as a colorless oil (940 mg, quant.). 1H NMR (500 MHz, CDCl3): d 6.14 (s, 2H), 3.80 (s,
3H), 3.80 (s, 6H), 3.71 (t, J = 6.4 Hz, 3H), 2.89 (t, J = 6.4 Hz, 2H), 1.96 (br s, OH); 13C NMR
(125 MHz, CDCl3): d 159.8, 159.2, 107.6, 90.7, 63.1, 55.8, 55.5, 26.2. The spectral
characteristics were identical to those reported in the current literature (Lal et al., 1987).
Appendix 1—scheme 3. Mitsunobu reaction on phenethyl alcohols.
General Mitsunobu reaction protocol
Diethyl azodicarboxylate (DEAD; 40% in toluene; 1.10 equiv) was added dropwise over 5–10
min to a solution of PPh3 (1.15 equiv), phthalimide (1.15 equiv) and the corresponding alcohol
S1–S5 (1.00 equiv) in THF (0.15 M) at 0˚C. The resulting mixture was allowed to warm to rt
over 3 hr and stirring was continued for 14 hr. The resulting pale-yellow solution was
concentrated under reduced pressure and purified by flash column chromatography to afford
the desired phthalimide protected amine S6–S10.
Appendix 1—chemical structure 6. Dimethoxyphenethyl phthalimide (S6).
2-(2,3-Dimethoxyphenethyl)isoindoline-1,3-dione (S6). Following the general Mitsunobu
reaction protocol, purification by flash column chromatography (hexanes:EtOAc 5:1) afforded
phthalimide protected amine S6 as a colorless solid (2.90 g, 85% yield) using alcohol S1 (2.00
g, 11.0 mmol) as starting material. 1H NMR (500 MHz, CDCl3): d 7.85–7.78 (m, 2H), 7.73–7.66
(m, 2H), 6.94 (t, J = 7.9 Hz, 1H), 6.83–6.74 (m, 2H), 3.95–3.91 (m, 2H), 3.89 (s, 3H), 3.83 (s, 3H),
3.07–2.97 (m, 2H); 13C NMR (125 MHz, CDCl3): d 168.2, 152.8, 147.7, 133.8, 132.2, 131.9,
123.8, 123.1, 122.3, 111.3, 60.8, 55.7, 38.5, 29.1. The spectral characteristics were identical to
those reported in the current literature (Selvakumar and Ramanathan, 2011).
Appendix 1—chemical structure 7. Dimethoxyphenethyl phthalimide (S7).
2-(3,5-Dimethoxyphenethyl)isoindoline-1,3-dione (S7). Following the general Mitsunobu
reaction protocol, purification by flash column chromatography (hexanes:EtOAc 3:1) afforded
phthalimide protected amine S7 as a colorless solid (1.70 g, 99% yield) using alcohol S2 (1.00
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g, 5.50 mmol) as starting material. 1H NMR (500 MHz, CDCl3): d 7.84 (dd, J = 5.4, 3.1 Hz, 2H),
7.71 (dd, J = 5.4, 3.1 Hz, 2H), 6.45–6.38 (m, 2H), 6.32 (t, J = 2.2 Hz, 1H), 3.96–3.89 (m, 2H),
3.75 (s, 6H), 2.96–2.91 (m, 2H); 13C NMR (125 MHz, CDCl3): d 168.3, 161.0, 140.4, 134.0,
132.2, 123.3, 106.8, 99.0, 55.4, 39.2, 35.0; Rf = 0.33 (hexanes:EtOAc 3:1). The spectral
characteristics were identical to those reported in the current literature (Selvakumar and
Ramanathan, 2011).
Appendix 1—chemical structure 8. Dimethoxyphenethyl phthalimide (S8).
2-(2,5-Dimethoxyphenethyl)isoindoline-1,3-dione (S8). Following the general Mitsunobu
reaction protocol, purification by flash column chromatography (hexanes:EtOAc 5:1) afforded
phthalimide protected amine S8 as a colorless solid (3.15 g, 98% yield) using alcohol S3 (1.85
g, 10.2 mmol) as starting material. 1H NMR (500 MHz, CDCl3): d 7.79–7.71 (m, 2H), 7.68–7.59
(m, 2H), 6.70–6.63 (m, 3H), 3.90 (t, J = 7.1 Hz, 2H), 3.66 (s, 3H), 3.62 (s, 3H), 2.93 (t, J = 7.1 Hz,
2H); 13C NMR (125 MHz, CDCl3): d 168.1, 153.3, 152.0, 133.7, 132.1, 127.6, 123.0, 116.6,
112.2, 111.1, 55.7, 55.6, 37.8, 29.6; Rf = 0.28 (hexanes:EtOAc 5:1). The spectral characteristics
were identical to those reported in the current literature (Selvakumar and Ramanathan,
2011).
Appendix 1—chemical structure 9. Trimethoxyphenethyl phthalimide (S9).
2-(2,3,4-Trimethoxyphenethyl)isoindoline-1,3-dione (S9). Following the general
Mitsunobu reaction protocol, purification by flash column chromatography (hexanes:EtOAc
5:1) afforded phthalimide protected amine S9 as a colorless solid (1.55 g, 96% yield) using
alcohol S4 (1.00 g, 4.71 mmol) as starting material. 1H NMR (500 MHz, CD3OD): d 7.85–7.70
(m, 4H), 6.78 (d, J = 8.5 Hz, 1H), 6.60 (d, J = 8.5 Hz, 1H), 3.86 (t, J = 6.8 Hz, 2H), 3.82 (s, 3H),
3.77 (s, 3H), 3.65 (s, 3H), 2.93–2.87 (m, 2H); 13C NMR (125 MHz, CD3OD): d 169.7, 154.1,
153.5, 143.4, 135.3, 135.2, 126.0, 124.1, 123.9, 108.7, 61.3, 60.9, 56.4, 39.7, 29.8; Rf = 0.18
(hexanes:EtOAc 3:1). The spectral characteristics were identical to those reported in the
current literature (Selvakumar and Ramanathan, 2011).
Appendix 1—chemical structure 10. Trimethoxyphenethyl phthalimide (S10).
2-(2,4,6-Trimethoxyphenethyl)isoindoline-1,3-dione (S10). Following the general
Mitsunobu reaction protocol, purification by flash column chromatography (hexanes:EtOAc
3:1) afforded phthalimide protected amine S9 as a colorless solid (1.60 g, 99% yield) using
alcohol S5 (1.00 g, 4.71 mmol) as starting material. IR (thin film) n 3248, 2928, 2850, 1772,
1715, 1634, 1607, 1439, 1205, 1139, 809 cm-1; 1H NMR (500 MHz, CDCl3): d 7.84–7.73 (m,
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 51 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
2H), 7.71–7.62 (m, 2H), 6.00 (s, 2H), 3.85 (t, J = 6.3 Hz, 2H), 3.76 (s, 3H), 3.59 (s, 6H), 2.97 (t,
J = 6.3 Hz, 2H); 13C NMR (125 MHz, CDCl3): d 168.4, 160.0, 159.2, 133.6, 132.5, 122.9, 107.4,
90.2, 55.5, 55.3, 37.6, 21.6; Rf = 0.20 (hexanes:EtOAc 3:1); ESI-HRMS calcd for C18H18NO4
[M+H] 312.1230, found 312.1223.
Appendix 1—scheme 4. Hydrazinolysis of phenethyl phthalimides.
General phthalimide deprotection protocol
Hydrazine monohydrate (10.0 equiv) was added to a suspension of the phthalimide protected
amine S6 – S10 in EtOH (0.15 M). The resulting solution was heated to reflux for 1.5 hr while
colorless solids crashed out. The resulting suspension was allowed to cool to rt before H2O
(20–50 mL) was added in one portion. Stirring was continued to afford a clear solution that
was extracted with EtOAc (3  50 mL). The combined organic layers were washed with H2O (3
 20 mL), brine (2  20 mL), dried over anhydrous Na2SO4, filtered and concentrated under
reduced pressure to yield analytically pure amine S11–S15 that was used in the next step
without further purification.
Appendix 1—chemical structure 11. Dimethoxyphenethyl amine (S11).
2-(2,3-Dimethoxyphenyl)ethan-1-amine (S11). Following the general phthalimide
deprotection protocol using phthalimide protected amine S6 (1.00 g, 3.21 mmol), primary
amine S11 was obtained as a colorless oil (500 mg, 86% yield). 1H NMR (500 MHz, CD3OD): d
6.99 (dd, J = 8.0, 7.7 Hz, 1H), 6.88 (dd, J = 8.0, 1.5 Hz, 1H), 6.78 (dd, J = 7.7, 1.6 Hz, 1H), 3.84
(s, 3H), 3.79 (s, 3H), 2.88–2.80 (m, 2H), 2.80–2.73 (m, 2H); NH2-group is not visible;
13C NMR
(125 MHz, CD3OD): d 154.2, 148.6, 134.3, 125.1, 123.4, 112.1, 61.0, 56.2, 43.5, 34.5. The
spectral characteristics were identical to those reported in the current literature (Yang et al.,
2013).
Appendix 1—chemical structure 12. Dimethoxyphenethyl amine (S12).
2-(3,5-Dimethoxyphenyl)ethan-1-amine (S12). Following the general phthalimide
deprotection protocol using phthalimide protected amine S7 (400 mg, 1.28 mmol), primary
amine S12 was obtained as a colorless oil (140 mg, 60% yield). 1H NMR (500 MHz, CD3OD): d
6.41–6.36 (m, 2H), 6.35 (t, J = 2.3 Hz, 1H), 3.76 (s, 6H), 2.92 (t, J = 7.3 Hz, 2H), 2.72 (t, J = 7.3
Hz, 2H), NH2-group is not visible;
13C NMR (125 MHz, CD3OD): d 162.5, 142.6, 107.8, 99.3,
55.7, 43.6, 39.4. The spectral characteristics were identical to those reported in the current
literature (Kinney et al., 2016).
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Appendix 1—chemical structure 13. Dimethoxyphenethyl amine (S13).
2-(2,5-Dimethoxyphenyl)ethan-1-amine (S13). Following the general phthalimide
deprotection protocol using phthalimide protected amine S8 (500 mg, 1.61 mmol), primary
amine S13 was obtained as a colorless oil (250 mg, 86% yield). 1H NMR (500 MHz, CDCl3): d
6.96–6.57 (m, 3H), 3.78 (s, 3H), 3.76 (s, 3H), 3.04–2.85 (m, 3H), 2.75 (t, J = 6.9 Hz, 2H), 1.90 (br
s, NH2);
13C NMR (125 MHz, CDCl3): d 153.5, 152.0, 129.2, 117.0, 111.4, 111.3, 55.9, 55.7,
42.1, 34.6. The spectral characteristics were identical to those reported in the current
literature (Sˇula´kova´ et al., 2019).
Appendix 1—chemical structure 14. Trimethoxyphenethyl amine (S14).
2-(2,3,4-Trimethoxyphenyl)ethan-1-amine (S14). Following the general phthalimide
deprotection protocol using phthalimide protected amine S9 (1.40 g, 4.10 mmol), primary
amine S14 was obtained as a colorless oil (600 mg, 69% yield). 1H NMR (500 MHz, CDCl3): d
6.83 (d, J = 8.5 Hz, 1H), 6.61 (d, J = 8.5 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.83 (s, 3H), 2.90 (t,
J = 7.0 Hz, 2H), 2.70 (t, J = 7.0 Hz, 2H), 1.51 (br s, NH2);
13C NMR (125 MHz, CDCl3): d 152.4,
152.2, 142.5, 125.8, 124.5, 107.3, 61.1, 60.8, 56.1, 43.1, 34.2. The spectral characteristics were
identical to those reported in the current literature (Yang et al., 2013).
Appendix 1—chemical structure 15. Trimethoxyphenethyl amine (S15).
2-(2,4,6-Trimethoxyphenyl)ethan-1-amine (S15). Following the general phthalimide
deprotection protocol using phthalimide protected amine S10 (1.60 g, 4.69 mmol), primary
amine S15 was obtained as a colorless oil (693 mg, 70% yield). IR (thin film) n 3426, 2938,
2838, 1593, 1498, 1455, 1417, 1204, 1148 cm-1; 1H NMR (500 MHz, CD3OD): d 6.20 (s, 2H),
3.79 (s, 6H), 3.79 (s, 3H), 2.79–2.71 (m, 4H), NH2-group is not visible;
13C NMR (125 MHz,
CD3OD): d 161.5, 160.4, 108.1, 91.5, 56.0, 56.0, 55.7, 41.9, 25.8; ESI-HRMS calcd for
C11H18NO3 [M+H] 212.1281, found 212.1280.
Appendix 1—scheme 5. Practical demethylation of aryl methyl ethers.
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General methyl ether cleavage protocol
BBr3 (1.0 M in CH2Cl2; 1.15 equiv for each OMe group) was added dropwise to a solution of
the 2-(methoxyphenyl)ethyl amine S11–S15 (1.00 equiv) in CH2Cl2 (0.025 M) at –78˚C. The
resulting mixture was allowed to warm to rt over 3 hr. Stirring was continued for 14 hr. The
resulting suspension was cooled to 0˚C and quenched with the dropwise addition of MeOH
(ca. 5 mL). Stirring at rt was continued for 1 hr. The resulting suspension was concentrated
under reduced pressure to afford a pale-brown oil. The obtained residue was dissolved in a
small amount of MeOH and again concentrated under reduced pressure; this step was
repeated 3–4 times to remove all of the trimethyl borate side product and obtain analytically
pure 2-(2-aminoethyl)benzenediol /-triol derivatives S16–S20 as HBr salts.
Appendix 1—chemical structure 16. Aminoethylbenzene diol hydrobromide (S16).
3-(2-Aminoethyl)benzene-1,2-diol hydrobromide (S16). Following the general phenol
ether cleavage protocol using phenol ether S11 (200 mg, 1.10 mmol), catechol amine S16 was
obtained as a brown oil (250 mg, 97% yield). 1H NMR (500 MHz, CD3OD): d 6.73 (dd, J = 6.7,
2.7 Hz, 1H), 6.69–6.56 (m, 2H), 3.17 (t, J = 7.4 Hz, 2H), 2.95 (t, J = 7.4 Hz, 2H), OH- and NH-
protons are not visible; 13C NMR (125 MHz, CD3OD): d 146.0, 144.6, 124.4, 122.3, 120.8,
115.4, 40.8, 29.4. The spectral characteristics were identical to those reported in the current
literature (Short et al., 1973).
Appendix 1—chemical structure 17. Aminoethylbenzene diol hydrobromide (S17).
5-(2-Aminoethyl)benzene-1,3-diol hydrobromide (S17). Following the general phenol ether
cleavage protocol using phenol ether S12 (20 mg, 0.110 mmol), resorcinol amine S17 was
obtained as a brown oil (25.0 mg, 97% yield). IR (thin film) n 3358, 2928, 2853, 1771, 1597,
1495, 1418, 1091, 844 cm-1; 1H NMR (500 MHz, CD3OD): d 6.33–6.08 (m, 2H), 3.13 (t, J = 7.6
Hz, 2H), 2.80 (t, J = 7.6 Hz, 2H), OH- and NH-protons are not visible; 13C NMR (125 MHz,
CD3OD): d 160.0, 139.9, 108.1, 102.4, 41.9, 34.5; ESI-HRMS calcd for C8H12NO2 [M+H]
154.0863, found 154.0860.
Appendix 1—chemical structure 18. 5-(2-Aminoethyl)benzene-1,4-diol hydrobromide (S18).
5-(2-Aminoethyl)benzene-1,4-diol hydrobromide (S18). Following the general phenol
ether cleavage protocol using phenol ether S13 (100 mg, 0.552 mmol), diol amine S18 was
obtained as a brown oil (118 mg, 91% yield). IR (thin film) n 3352, 2927, 2858, 1621, 1505,
1455, 1344, 1202, 1152, 1212 cm-1; 1H NMR (500 MHz, CD3OD): d 6.66 (d, J = 8.5 Hz, 1H),
6.63–6.46 (m, 2H), 3.15 (t, J = 7.2 Hz, 2H), 2.88 (t, J = 7.2 Hz, 2H), OH- and NH-protons are
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 54 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
not visible; 13C NMR (125 MHz, CD3OD): d 151.1, 149.4, 124.9, 118.2, 116.9, 115.8, 40.9, 29.9;
ESI-HRMS calcd for C8H12NO2 [M+H] 154.0863, found 154.0852.
Appendix 1—chemical structure 19. Aminoethylbenzene triol hydrobromide (S19).
4-(2-Aminoethyl)benzene-1,2,3-triol hydrobromide (S19). Following the general phenol
ether cleavage protocol using phenol ether S14 (200 mg, 0.948 mmol), triol amine S19 was
obtained as a brown oil (240 mg, quant.). IR (thin film) n 3357, 3222, 2537, 1620, 1484, 1282,
1230, 1182, 1100, 1053, 1016 cm-1; 1H NMR (500 MHz, CD3OD): d 6.48 (d, J = 8.2 Hz, 1H),
6.32 (d, J = 8.2 Hz, 1H), 3.12 (t, J = 7.3 Hz, 2H), 2.87 (t, J = 7.3 Hz, 2H), OH- and NH-protons
are not visible; 13C NMR (125 MHz, CD3OD): d 146.6, 145.7, 134.4, 121.4, 115.9, 108.0, 41.2,
29.5; ESI-HRMS calcd for C8H12NO3 [M+H] 170.0812, found 170.0805.
Appendix 1—chemical structure 20. Aminoethylbenzene triol hydrobromide (S20).
2-(2-Aminoethyl)benzene-1,3,5-triol hydrobromide (S20). Following the general phenol
ether cleavage protocol using phenol ether S15, triol amine S20 was obtained, according to
MS identification, in low quantities along with brominated species and various
methoxybenzene-diols in an inseparable mixture.
Initial attempts to alter reaction temperature or the number of equivalents of BBr3 resulted
in low conversion. Heating phenol ether S15 in the presence of iodo(trimethyl)silane
(Anderson et al., 2005) or sodium ethanethiolate (Lutz et al., 1996) afforded mono-
deprotected material in a cleaner reaction, but the desired triol amine S20 was not observed.
Due to our inability to access this substrate, we did not evaluate this substrate in any enzyme
reactions in our study.
Benzaldehydes as starting materials
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Appendix 1—scheme 6. Preparation of aminoethylbenzene triol hydrobromide from aryl
nitriles.
Appendix 1—chemical structure 21. Trimethoxybenzonitrile (S21).
2,3,5-Trimethoxybenzonitrile (S21). K2CO3 (1.90 g, 13.8 mmol, 1.50 equiv) and dimethyl
sulfate (0.960 mL, 1.28 g, 10.1 mmol, 1.10 equiv) were added to a solution of 5-hydroxy-2,3-
dimethoxybenzonitrile (Fu¨rstner et al., 2002) (1.65 g, 9.21 mmol, 1.00 equiv) in acetone (30
mL) at rt. Stirring was continued for 18 hr to afford a pale beige suspension. The solvent was
removed under reduced pressure and the resulting crude material was diluted with a mixture
of EtOAc–H2O (1:1; 100 mL). The obtained layers were separated and the aqueous layer was
extracted with EtOAc (3  20 mL). The combined organic layers were washed with 5%
aqueous NaOH (20 mL) and brine (2  20 mL), dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure to afford analytically pure trimethoxybenzonitrile S21
(1.78 g, quant.) as a pale beige solid. 1H NMR (500 MHz, CDCl3): d 6.68 (d, J = 2.8 Hz, 1H),
6.56 (d, J = 2.8 Hz, 1H), 3.94 (s, 3H), 3.86 (s, 3H), 3.79 (s, 3H). The spectral characteristics were
identical to those reported in the current literature (Rizzacasa and Sargent, 1988).
Appendix 1—chemical structure 22. Trimethoxybenzaldehyde (S22).
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 56 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
2,3,5-Trimethoxybenzaldehyde (S22). DIBAL-H (1.0 M in CH2Cl2; 12.4 mL, 12.4 mmol, 1.50
equiv) was added dropwise to a solution of nitrile S21 (1.60 g, 8.28 mmol, 1.00 equiv) in
CH2Cl2 (33 mL) at 0˚C. The resulting mixture was allowed to warm to rt over 3 hr after which
stirring was continued for 8 hr. The reaction was cooled to 0˚C and HCl (1.0 M in H2O; 10.0
mL) was added dropwise over 10 min. The mixture was allowed to warm to rt and stirring was
continued for 2 hr. The layers were separated, and the aqueous layer was extracted with
CH2Cl2 (2  15 mL). The combined organic layers were washed with H2O (2  15 mL) and
brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced
pressure to afford analytically pure benzaldehyde S22 (845 mg, 52%) as a beige solid. 1H NMR
(500 MHz, CDCl3): d 10.40 (s, 1H), 6.86 (d, J = 2.9 Hz, 1H), 6.74 (d, J = 2.9 Hz, 1H), 3.93 (s,
3H), 3.89 (s, 3H), 3.82 (s, 3H); 13C NMR (125 MHz, CDCl3): d 190.2, 156.4, 154.4, 148.2, 129.9,
107.7, 99.7, 63.1, 56.4, 56.1. The spectral characteristics were identical to those reported in
the current literature (Singh et al., 1995).
Appendix 1—chemical structure 23. Nitrovinyl benzene (S23).
(E) 1,2,5-Trimethoxy-3-(2-nitrovinyl)benzene (S23). A mixture of benzaldehyde S22 (845
mg, 4.31 mmol, 1.00 equiv) and ammonium acetate (500 mg, 6.46 mmol, 1.50 equiv) in
nitromethane (40 mL) was heated to reflux for 18 hr, after which the reaction was found to be
complete according to TLC (Rf = 0.38 starting material; Rf = 0.35 product; hexanes:EtOAc
4:1). The resulting mixture was concentrated under reduced pressure and purified by flash
column chromatography (hexanes:EtOAc 6:1) to afford nitrovinyl benzene S23 (750 mg, 73%)
as a yellow solid. IR (thin film) n 2959, 2846, 1717, 1633, 1601, 1492, 1465, 1332, 1282, 1206,
1176, 1151 cm-1; 1H NMR (500 MHz, CDCl3): d 8.16 (d, J = 13.8 Hz, 1H), 7.71 (d, J = 13.8 Hz,
1H), 6.61 (d, J = 2.6 Hz, 1H), 6.48 (d, J = 2.6 Hz, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.80 (s, 3H); 13C
NMR (125 MHz, CDCl3): d 156.4, 154.1, 144.2, 138.7, 134.8, 124.0, 104.5, 102.9, 61.6, 56.1,
55.9; Rf = 0.35 (hexanes:EtOAc 4:1); ESI-HRMS calcd for C11H14NO5 [M+H] 240.0866, found
240.0871.
Appendix 1—chemical structure 24. Trimethoxyphenethyl amine (S24).
2-(2,3,5-Trimethoxyphenyl)ethan-1-amine (S24). LiAlH4 (2.0 M in THF; 1.83 mL, 3.66
mmol, 3.50 equiv) was added dropwise over 10 min to a solution of nitrovinyl benzene S23
(250 mg, 1.05 mmol, 1.00 equiv) in THF (6 mL) at 0˚C. The resulting mixture was allowed to
warm to rt and stirring was continued for 24 hr. The reaction mixture was then cooled to 0˚C
and 10% aqueous NaOH (5.0 mL) was added dropwise over 10 min, resulting in an exothermic
reaction. Stirring was continued for 1 hr, and the resulting suspension was diluted with EtOAc
(20 mL) and filtered over a plug of Celite (EtOAc rinse). The filtrate was dried over anhydrous
Na2SO4, filtered, and concentrated under reduced pressure to afford crude amine S24.
Purification by flash column chromatography (EtOAc:MeOH 85:15 + 0.1% Et3N) afforded
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amine S24 (150 mg, 68%) as a pale yellow oil. IR (thin film) n 3363, 2937, 2839, 1599, 1492,
1465, 1427, 1380, 1220, 1175, 1150, 1089, 830 cm-1; 1H NMR (500 MHz, CDCl3): d 6.39 (d,
J = 2.5 Hz, 1H), 6.29 (d, J = 2.5 Hz, 1H), 3.84 (s, 3H), 3.77 (s, 3H), 3.76 (s, 3H), 2.97 (t, J = 7.0
Hz, 2H), 2.78 (t, J = 7.0 Hz, 2H), 2.27 (br s, NH2);
13C NMR (125 MHz, CDCl3): d 156.0, 153.5,
141.5, 133.4, 105.5, 98.5, 60.9, 55.7, 55.6, 42.7, 34.1; Rf = 0.08 (EtOAc:MeOH 85:15); ESI-
HRMS calcd for C11H18NO3 [M+H] 212.1281, found 212.1275.
Appendix 1—chemical structure 25. Aminoethylbenzene triol hydrobromide (S25).
3-(2-Aminoethyl)benzene-1,2,5-triol hydrobromide (S25). BBr3 (1.0 M in CH2Cl2; 1.41 mL,
1.41 mmol, 3.30 equiv) was added dropwise over 10 min to a solution of phenol ether S24
(90.0 mg, 0.425 mmol, 1.00 equiv) in CH2Cl2 (0.033 M) at –78˚C. The resulting mixture was
allowed to warm to rt over 3 hr. Stirring was continued for 18 hr. The resulting suspension was
cooled to 0˚C and quenched with the dropwise addition of MeOH (ca. 5 mL). Stirring at rt was
continued for 1 hr. The resulting solution was concentrated under reduced pressure to afford a
pale-brown oil. The obtained residue was dissolved in a small amount of MeOH and again
concentrated under reduced pressure; this step was repeated 3–4 times to remove all of the
trimethyl borate side product and obtain analytically pure triol amine S25 as the HBr salt. IR
(thin film) n 3358, 3223, 1604, 1452, 1359, 1291, 1108, 1044 cm-1; 1H NMR (500 MHz, CD3OD):
d 6.29 (d, J = 2.6 Hz, 1H), 6.11 (d, J = 2.8 Hz, 1H), 3.15 (t, J = 7.4 Hz, 2H), 2.88 (t, J = 7.3 Hz,
2H), OH- and NH-protons are not visible; 13C NMR (125 MHz, CD3OD): d 151.4, 147.1, 137.7,
125.0, 108.2, 103.3, 41.0, 29.8; ESI-HRMS calcd for C8H12NO3 [M+H] 170.0812, found
170.0812.
Appendix 1—scheme 7. Preparation of aminoethylbenzene triol hydrobromide derivatives from
trimethoxybenzene.
Appendix 1—chemical structure 26. Trimethoxy nitrovinyl benzene (S26).
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(E) 1,2,4-Trimethoxy-3-(2-nitrovinyl)benzene (S26). A mixture of 2,3,6-
trimethoxybenzaldehyde15 (500 mg, 2.55 mmol, 1.00 equiv) and ammonium acetate (295 mg,
3.82 mmol, 1.50 equiv) in nitromethane (23 mL) was heated to reflux for 18 hr after which the
reaction was found to be according to TLC (Rf = 0.30 starting material; Rf = 0.38 product;
hexanes:EtOAc 2:1). The resulting mixture was concentrated under reduced pressure and
purified by flash column chromatography (hexanes:EtOAc 5:1) to afford nitrovinyl benzene
S26 (500 mg, 82%) as a yellow solid. IR (thin film) n 2939, 2854, 1625, 1583, 1507, 1496, 1330,
1284, 1116, 1009 cm-1; 1H NMR (500 MHz, CD3OD): d 8.39 (d, J = 13.7 Hz, 1H), 8.09 (d,
J = 13.7 Hz, 1H), 7.17 (d, J = 9.2 Hz, 1H), 6.80 (d, J = 9.2 Hz, 1H), 3.91 (s, 3H), 3.91 (s, 3H),
3.85 (s, 3H); 13C NMR (125 MHz, CD3OD): d 155.5, 151.6, 148.2, 140.8, 130.7, 118.7, 114.7,
107.1, 61.6, 57.0, 56.6; Rf = 0.38 (hexanes:EtOAc 2:1); ESI-HRMS calcd for C11H14NO5 [M+H]
240.0866, found 240.0860.
Appendix 1—chemical structure 27. Trimethoxyphenethyl amine (S27).
2-(2,3,6-Trimethoxyphenyl)ethan-1-amine (S27). LiAlH4 (2.0 M in THF; 3.66 mL, 7.32
mmol, 3.50 equiv) was added dropwise over 10 min to a solution of nitrovinyl benzene S26
(200 mg, 2.09 mmol, 1.00 equiv) in THF (12 mL) at 0˚C. The resulting mixture was allowed to
warm to rt and stirring was continued for 24 hr. The reaction mixture was cooled to 0˚C and
10% aqueous NaOH (10.0 mL) was added dropwise over 10 min, resulting in an exothermic
reaction. Stirring was stirred continued for 1 hr. The resulting suspension was diluted with
EtOAc (20 mL) and filtered over a plug of Celite (EtOAc rinse). The filtrate was dried over
anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford analytically
pure amine S27 (438 mg, quant.) as a pale yellow oil. IR (thin film) n 3363, 2936, 2833, 1648,
1485, 1463, 1253, 1085, 793, 627 cm-1; 1H NMR (500 MHz, CDCl3): d 6.73 (d, J = 8.8 Hz, 1H),
6.55 (d, J = 8.8 Hz, 1H), 3.82 (s, 3H), 3.82 (s, 3H), 3.76 (s, 3H), 2.88 (d, J = 6.0 Hz, 2H), 2.83 (d,
J = 6.0 Hz, 2H), 2.47 (br s, NH2);
13C NMR (125 MHz, CDCl3): d 152.5, 148.4, 147.2, 122.7,
110.2, 105.4, 60.8, 56.2, 55.9, 42.2, 28.5; Rf = 0.10 (EtOAc:MeOH 85:15); ESI-HRMS calcd for
C11H18NO3 [M+H] 212.1281, found 212.1273.
Appendix 1—chemical structure 28. Aminoethylbenzene triol hydrobromide (S28).
3-(2-Aminoethyl)benzene-1,2,4-triol hydrobromide (S28). Following the general phenol
ether cleavage protocol described for the preparation of amine hydrobromide S25 using
phenol ether S27 as starting material, triol amine S28 was obtained, according to MS
identification, in low quantities along with brominated species. Initial attempts in changing the
reaction temperature or the number of equivalents of BBr3 resulted in low conversion and the
desired product could not be isolated in pure form. Therefore it was not used in any enzyme
assays.
Preparation of 2-amino-4-(2-aminoethyl)phenol
All reactions were carried out with degassed solvents under a positive pressure of nitrogen.
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Appendix 1—scheme 8. 2-Amino-4-(2-aminoethyl)phenol via Mitsunobu strategy.
Appendix 1—chemical structure 29. Benzyloxy nitrophenethyl alcohol (S29).
2-(4-(Benzyloxy) 3-nitrophenyl)ethan-1-ol (S29). (Bromomethyl)benzene (3.02 mL, 4.34 g,
25.4 mmol, 2.50 equiv) was added dropwise to a suspension of commercially available 2-(4-
hydroxy-3-nitrophenyl)acetic acid (2.00 g, 10.1 mmol, 1.00 equiv), anhydrous potassium
carbonate (4.21 g, 30.4 mmol, 3.00 equiv), and anhydrous potassium iodide (674 mg, 4.06
mmol, 0.400 equiv) in acetone (34 mL) at rt. Vigorously stirring was continued for 48 hr. The
resulting suspension was diluted with a mixture of EtOAc-H2O (1:1; 100 mL), cooled to 0˚C,
and adjusted to pH = 1 using aqueous 1M HCl. This resulted in an exothermic reaction. The
layers were separated, and the aqueous layer was extracted with EtOAc (3  15 mL). The
combined organic layers were washed with H2O (2  15 mL), brine (30 mL), dried over
anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford crude 2-(4-
(benzyloxy) 3-nitrophenyl)acetic acid, which was immediately used in the next step without
further purification.
BH3 . SMe2 (2.0 M in THF; 6.57 mL, 13.1 mmol, 1.30 equiv) was added dropwise to a
solution of the crude 2-(4-(benzyloxy) 3-nitrophenyl)acetic acid in THF (110 mL) at 0˚C. The
resulting mixture was allowed to warm to rt over 3 hr and stirring was continued for 14 hr. The
resulting suspension was cooled to 0˚C and carefully quenched with the dropwise addition of
saturated aqueous NaHCO3. The layers were separated, and the aqueous layer was extracted
with EtOAc (3  50 mL). The combined organic layers were washed with H2O (2  20 mL),
brine (2  20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced
pressure to afford crude alcohol S29 as a brown oil. Purification by flash column
chromatography (hexanes:EtOAc 1:1) afforded analytically pure alcohol (1.98 g, 72%) as a pale
yellow oil. 1H NMR (500 MHz, CDCl3): d 7.71 (d, J = 2.3 Hz, 1H), 7.46–7.29 (m, 6H), 7.05 (d,
J = 8.6 Hz, 1H), 5.19 (s, 2H), 3.82 (t, J = 6.5 Hz, 2H), 2.81 (t, J = 6.5 Hz, 2H), 1.90 (br s, OH);
13C NMR (125 MHz, CDCl3): d 150.5, 140.0, 135.8, 134.8, 131.8, 128.7, 128.2, 127.0, 125.9,
115.4, 71.3, 63.0, 37.7; Rf = 0.18 (hexanes:EtOAc 1:1). The spectral characteristics were
identical to those reported in the current literature (Lin et al., 2005).
Appendix 1—chemical structure 30. Benzyloxy nitrophenethyl phthalimide (S30).
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2-(4-(Benzyloxy) 3-nitrophenethyl)isoindoline-1,3-dione (S30). Diethyl azodicarboxylate
(DEAD; 40% in toluene; 3.95 mL, 8.05 mmol, 1.10 equiv) was added dropwise over 10 min to a
solution of PPh3 (2.21 g, 8.42 mmol, 1.15 equiv), phthalimide (1.24 g, 8.42 mmol, 1.15 equiv)
and the alcohol S29 (1.98 g, 7.32 mmol, 1.00 equiv) in THF (50 mL) at 0˚C. The resulting
mixture was allowed to warm to rt over 3 hr and stirring was continued for 14 hr. The resulting
pale-yellow solution was concentrated under reduced pressure and purified by flash column
chromatography (hexanes:EtOAc 4:1) to afford the desired phthalimide protected amine S30
(2.28 g, 78%) as a colorless solid. IR (thin film) n 2985, 2871, 2783, 1774, 1750, 1640, 1387,
1307, 717 cm-1; 1H NMR (500 MHz, CDCl3): d 7.94–7.80 (m, 2H), 7.78–7.67 (m, 3H), 7.50–7.30
(m, 6H), 7.05 (d, J = 8.6 Hz, 1H), 5.20 (s, 2H), 3.91 (t, J = 7.5 Hz, 2H), 2.99 (t, J = 7.5 Hz, 2H);
13C NMR (125 MHz, CDCl3): d 168.2, 150.8, 140.1, 135.7, 134.5, 134.2, 132.0, 130.9, 128.8,
128.3, 127.1, 126.0, 123.5, 115.6, 71.3, 38.8, 33.4; Rf = 0.18 (hexanes:EtOAc 1:1); ESI-HRMS
calcd for C23H19N2O5 [M+H] 403.1288, found 403.1266 and C22H19N2O5Na [M+Na] 425.1113,
found 425.1111.
Appendix 1—chemical structure 31. Amino alcohol (S31).
2-(3-Amino-4-hydroxyphenethyl)isoindoline-1,3-dione (S31). A flame dried round-
bottomed flask was charged with nitroarene S30 (100 mg, 0.250 mmol, 1.00 equiv) in a
mixture of EtOH-CH2Cl2 (1:1; 18 mL) at rt. Pd-C (10% on activated charcoal; 15 mg) was
added to the clear solution, which was purged with H2 for 15 min with the H2 inlet needle
below the solvent surface. The H2 inlet needle was raised above the solvent surface and
stirring was continued for 18 hr. The resulting black suspension was filtered over a short plug
of Celite (CH2Cl2 rinse). The filtrate was concentrated under reduced pressure to afford a
brown oil that was purified by flash column chromatography (hexanes:EtOAc 1:1) to afford the
desired amino alcohol S31 (70 mg, quant.) as a yellow solid. IR (thin film) n 3373, 2941, 2824,
1410, 1022, 1005, 822, 760, 617 cm-1; 1H NMR (500 MHz, DMSO-d6): d 8.77 (br s, OH), 7.96–
7.72 (m, 4H), 6.50 (d, J = 7.9 Hz, 1H), 6.46 (d, J = 2.0 Hz, 1H), 6.20 (dd, J = 7.9, 2.1 Hz, 1H),
4.45 (br s, NH2), 3.69 (t, J = 7.6, 2H), 2.67 (t, J = 7.6, 2H);
13C NMR (125 MHz, DMSO-d6): d
167.7, 142.5, 136.5, 134.4, 131.6, 128.9, 123.0, 116.3, 114.6, 114.3, 39.5, 33.4; Rf = 0.20
(hexanes:EtOAc 1:1); ESI-HRMS calcd for C16H15N2O3 [M+H] 283.1077 found 283.1066 and
C16H14N2O3Na [M+Na] 305.0902, found 305.0880.
Appendix 1—chemical structure 32. 2-Amino-4-(2-aminoethyl)phenol (S32).
2-Amino-4-(2-aminoethyl)phenol (S32). Hydrazine monohydrate (120 mL, 2.48 mmol, 10.0
equiv) was added to a suspension of the phthalimide protected amine S31 (70.0 mg, 0.248
mmol, 1.00 equiv) in EtOH (1.5 mL). The resulting solution was heated to reflux for 1.5 hr while
colorless solids crashed out. The resulting suspension was allowed to cool to rt before H2O (10
mL) was added in one portion. Stirring was continued to afford a clear solution that was
extracted with EtOAc (3  5 mL). The combined organic layers were washed with H2O (3  5
mL), brine (3  5 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced
pressure to yield analytically pure amine S32 (18 mg, 48%). IR (thin film) n 3384, 2947, 2822,
1580, 1239, 1049, 1021, 837 cm-1; 1H NMR (500 MHz, CD3OD): d 6.66 (d, J = 8.0 Hz, 1H), 6.63
(d, J = 2.2 Hz, 1H), 6.47 (dd, J = 8.0, 2.2 Hz, 1H), 3.05 (t, J = 7.5 Hz, 2H), 2.75 (t, J = 7.5 Hz,
2H), OH- and NH-protons are not visible; 13C NMR (125 MHz, CD3OD): d 145.2, 136.4, 131.2,
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120.2, 117.7, 115.7, 43.6, 37.7; ESI-HRMS calcd for C8H13N2O [M+H] 153.1028 found
153.1019.
Preparation of hydroxytyrosol
Appendix 1—scheme 9. Reduction of a dihydroxyphenyl acetic acid.
4-(2-Hydroxyethyl)benzene-1,2-diol(S33). LiAlH4 (340 mg, 8.92 mmol, 5.00 equiv) was
added in small portions to a solution of commercially available 3,4-dihydroxyphenylacetic acid
(300 mg, 1.78 mmol, 1.00 equiv) in THF (35 mL) at 0˚C. The suspension was allowed to warm
to rt over 30 min before being heated to reflux for 18 hr. The resulting mixture was cooled to
0˚C and quenched with the slow addition of aqueous 0.5 M HCl (30 mL). The layers were
separated, and the aqueous layer was extracted with EtOAc (3  10 mL). The combined
organic layers were washed with H2O (2  10 mL), brine (2  10 mL), dried over anhydrous
Na2SO4, filtered, and concentrated under reduced pressure to afford an orange oil.
Purification by flash column chromatography (hexanes:EtOAc 1:1) afforded triol S33 (260 mg,
95%) as a pale red oil.1H NMR (500 MHz, CD3OD): d 6.74–6.60 (m, 2H), 6.58–6.48 (m, 1H),
3.67 (t, J = 7.2 Hz, 2H), 2.66 (t, J = 7.2 Hz, 2H), OH-protons are not visible; Rf = 0.20 (hexanes:
EtOAc 1:1). The spectral characteristics were identical to those reported in the current
literature (Napora-Wijata et al., 2014).
Additional information
. 2-Aminoethylbenzenediol /- triol derivatives (S16–S20, S25) as well as 2-amino-4-(2-amino-
ethyl)phenol S32 are sensitive towards oxidation and turn black within hours if stored in the
presence of O2. No noticeable change in their composition is observed, according to
1H
NMR, when stored in the absence of O2 at 3–4˚C.
. Salt formation of the oxygen sensitive alkylamines (S16–S20, S25, S32) leads to more stable
compounds as no decomposition was observed when stored in the presence of O2 for sev-
eral days.
. Upon quenching of the phenol ether cleavage reaction with MeOH, a reaction that contains
BBr3, volatile B(OMe)3 is formed as sole side product. This can be removed under reduced
pressure to afford pure products. It is important to stir the reaction mixture for approximately
1 hr upon the addition of MeOH to allow for the full conversion of BBr3 to B(OMe)3. The
obtained residue can be dissolved in additional MeOH and again concentrated under
reduced pressure to ensure the complete removal of B(OMe)3.
1H / 13C SPECTRA
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Appendix 1—figure 1. 1H NMR of dimethoxyphenethyl alcohol (S1).
Appendix 1—figure 2. 13C NMR of dimethoxyphenethyl alcohol (S1).
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Appendix 1—figure 3. 1H NMR of trimethoxyphenethyl alcohol (S4).
Appendix 1—figure 4. 13C NMR of trimethoxyphenethyl alcohol (S4).
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Appendix 1—figure 5. 1H NMR of trimethoxyphenethyl alcohol (S5).
Appendix 1—figure 6. 13C NMR of trimethoxyphenethyl alcohol (S5).
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Appendix 1—figure 7. 1H NMR of trimethoxyphenethyl phthalimide (S10).
Appendix 1—figure 8. 13C NMR of trimethoxyphenethyl phthalimide (S10).
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Appendix 1—figure 9. 1H NMR of dimethoxyphenethyl amine (S11).
Appendix 1—figure 10. 13C NMR of dimethoxyphenethyl amine (S11).
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Appendix 1—figure 11. 1H NMR of dimethoxyphenethyl amine (S12).
Appendix 1—figure 12. 13C NMR of dimethoxyphenethyl amine (S12).
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Appendix 1—figure 13. 1H NMR of trimethoxyphenethyl amine (S14).
Appendix 1—figure 14. 13C NMR of trimethoxyphenethyl amine (S14).
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Appendix 1—figure 15. 1H NMR of trimethoxyphenethyl amine (S15).
Appendix 1—figure 16. 13C NMR of trimethoxyphenethyl amine (S15).
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Appendix 1—figure 17. 1H NMR of aminoethylbenzene diol hydrobromide (S16).
Appendix 1—figure 18. 13C NMR of aminoethylbenzene diol hydrobromide (S16).
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Appendix 1—figure 19. 1H NMR of aminoethylbenzene diol hydrobromide (S17).
Appendix 1—figure 20. 13C NMR of aminoethylbenzene diol hydrobromide (S17).
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Appendix 1—figure 21. 1H NMR of aminoethylbenzene diol hydrobromide (S18).
Appendix 1—figure 22. 13C NMR of aminoethylbenzene diol hydrobromide (S18).
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Appendix 1—figure 23. 1H NMR of aminoethylbenzene triol hydrobromide (S19).
Appendix 1—figure 24. 13C NMR of aminoethylbenzene triol hydrobromide (S19).
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Appendix 1—figure 25. 1H NMR of nitrovinyl benzene (S23).
Appendix 1—figure 26. 13C NMR of nitrovinyl benzene (S23).
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Appendix 1—figure 27. 1H NMR of trimethoxyphenethyl amine (S24).
Appendix 1—figure 28. 13C NMR of trimethoxyphenethyl amine (S24).
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Appendix 1—figure 29. 1H NMR of aminoethylbenzene triol hydrobromide (S25).
Appendix 1—figure 30. 13C NMR of aminoethylbenzene triol hydrobromide (S25).
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Appendix 1—figure 31. 1H NMR of trimethoxy nitrovinyl benzene (S26).
Appendix 1—figure 32. 13C NMR of trimethoxy nitrovinyl benzene (S26).
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 78 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
Appendix 1—figure 33. 1H NMR of trimethoxyphenethyl amine (S27).
Appendix 1—figure 34. 13C NMR of trimethoxyphenethyl amine (S27).
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Appendix 1—figure 35. 1H NMR of benzyloxy nitrophenethyl alcohol (S29).
Appendix 1—figure 36. 13C NMR of benzyloxy nitrophenethyl alcohol (S29).
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Appendix 1—figure 37. 1H NMR of benzyloxy nitrophenethyl phthalimide (S30).
Appendix 1—figure 38. 13C NMR of benzyloxy nitrophenethyl phthalimide (S30).
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Appendix 1—figure 39. 1H NMR of amino alcohol (S31).
Appendix 1—figure 40. 13C NMR of amino alcohol (S31).
Maini Rekdal et al. eLife 2020;9:e50845. DOI: https://doi.org/10.7554/eLife.50845 82 of 83
Research article Biochemistry and Chemical Biology Microbiology and Infectious Disease
Appendix 1—figure 41. 1H NMR of 2-amino-4-(2-aminoethyl)phenol (S32).
Appendix 1—figure 42. 13C NMR of 2-amino-4-(2-aminoethyl)phenol (S32).
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